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Abstract :
The Type Three Secretion (T3S) system is a device used by many Gram-negative pathogens
that allows bacteria to deliver effector proteins straight into the eukaryotic cell cytosol. These
effectors interfere with various signaling pathways to subvert the host cell functions. The
secretion machinery of the T3S system consist of a basal body spanning the bacterial inner and
outer membrane followed by a stiff hollow needle outside the bacterium. The fully assembled
secretion apparatus constitute a continuous hollow conduit that connects the bacteria to the
eukaryotic target cell. After cell contact, virulence proteins -called effectors- are injected directly
into the cytosol of the host cell via the T3S apparatus. Several effectors of the T3S system
require the assistance of specific cytosolic chaperones to be efficiently exported. There are
three classes of T3S chaperones. Effector proteins are assisted by Class I chaperones.
Although Class I chaperones are well characterized, their main function is still a matter of
controversy.
In this thesis, we demonstrate that orf155 encodes a specific chaperone for the effector YopO
that we called SycO. We showed that SycO enhances YopO secretion in vitro and is required
for translocation of YopO into infected cells. By pulldown assay we demonstrated that residues
20 to 77 of YopO are required and sufficient for SycO binding. Using crosslinking experiments
and size exclusion chromatography analysis, we determined the stoichiometry of purified SycO
and YopO-SycO complexes. SycO alone forms dimers in solution and the YopO-SycO complex
has a 1:2 stoichiometry. These results suggested that SycO is a typical chaperone of the Class
I.
YopO is a serine/theronine kinase that interacts with Rho and Rac and disrupts the
cytoskeleton of the target cells. YopO has been shown to localize at the cell plasma-membrane.
By transfection of YopO-EGFP hybrid proteins into HEK293T cells, we demonstrated that the
chaperone-binding domain (CBD) coincides with the membrane localization domain of YopO.
Nevertheless, the CBD was not needed for the kinase activity of YopO. By ultracentrifugation,
we also showed that the CBD causes YopO aggregation in the bacteria, when SycO does not
cover it. Further, we show that the CBD of YopE and YopT also caused aggregation in the
bacteria in the absence of SycE and SycT respectively. YopE, YopT and T3S effectors in other
systems also act at the membrane of the eukaryotic host cell.
We propose a new hypothesis concerning the role of T3S chaperones. The sub-cellular
localization domain of effectors is aggregation-prone and creates the need for a chaperone
inside bacteria. We propose that masking such aggregation-prone localization domains may be
a general function for type III effector chaperones.
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The type III secretion system :
Bacterial interactions and cross-talk with animals or plants occurs in many different ways. The
bacterial-host relation can be symbiotic, commensal or pathogenic. This communication is often
mediated by bacterial secreted proteins acting on specific host cell targets. The outcome is the
modification of the host cell behavior and response regarding the bacterial presence.
One of the devices developed by Gram-negative bacteria to communicate with the eukaryotic
host cells is the type three secretion (T3S) system. Since the discovery of this secretion
pathway in the 1990’s, the recent sequencing of many bacterial genome revealed T3S to be
vastly distributed in Gram-negative bacteria (Fig. 1).  T3S systems are genetically encoded on
genomic (pathogenicity) islands or on virulence plasmids acquired by horizontal transfer. These
investigations also showed that this system is broadly involved in pathogenic relationships (Fig.
1) (Troisfontaines and Cornelis, 2005); (Mota et al., 2005).
The secretion machinery of the T3S system called injectisome (or needle complex), is related to
the bacterial flagellum. As they share many structural similarities, they are thought to have
evolved from a common ancestor (Gophna et al., 2003). The secretion apparatus consist of a
basal body: two rings, spanning the bacterial inner and outer membrane, linked by a rod. From
this membrane embedded structure protrudes a stiff hollow needle outside the bacterium (Fig.
2). In Yersinia, needles are tipped by a protein called LcrV which serves the assembly of a
translocation pore in the eukaryotic cell membrane (Mueller et al., 2005). The fully assembled
injectisome constitute a continuous hollow conduit connecting the bacteria to the eukaryotic cell.
After cell contact, the T3S apparatus injects virulence proteins, called effectors, directly into the
cytosol of the host cell. Effectors are translocated in one step, from the bacterial cytosol across
the inner membrane, the periplasm, the outer membrane, the lipopolysaccharide layer and the
eukaryotic cell membrane (Fig. 3). Inside the eukaryotic cell the effectors manipulate the host
cell response to the advantage of the bacterial pathogen, or of both organisms for symbionts. In
animals, the activity of some effectors allows bacteria to invade non-phagocytic cells, others
interfere with different signaling pathways, disturb the cytoskeleton dynamics, modify the pro-
inflammatory response, induce apoptosis, or modulate intracellular trafficking. The set of
translocated effectors varies between bacteria, according to their life style (symbiont or
pathogen, intra- or extra-cellular) and their host. In Yersinia, six effectors are injected into the
target cell. YopE, YopO, YopT are targeting small Rho-GTPases, disturbing cytoskeleton
dynamics. YopH disrupts focal adhesions. YopP/YopJ counteracts the pro-inflammatory
response and induces apoptosis in macrophages. Finally YopM appears to be translocated into
the nucleus of the infected cells, but its function remains unclear (Mota and Cornelis, 2005).
Effectors travel unfolded through the injectisome, from the bacterium straight into the eukaryotic
host cell cytosol (Blocker et al., 2001) ; (Feldman et al., 2002). The whole translocation process
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is energized by an ATPase (YscN) present at the entrance of the channel, in the basal body
(Woestyn et al., 1994); (Muller et al., 2006). The recognition of the T3S effectors is mediated by
a N-terminal signal sequence present in the first 15 residues of the proteins (Sory et al., 1995);
(Lloyd et al., 2001). In order to be operational in the assembly and fit for the export process,
some of the T3S substrates require the assistance of small, specific proteins called T3S
chaperones.
Figure 2 : Structure of the T3S
apparatus :
T3S needles protrude at the surface of
the bacteria (Black arrows, Fig. 2A and
2B). Needle complexes can be extracted
from the bacteria and isolated. Electronic
microscopy analysis of these complexes
allowed structural determination of the
core of the basal body, constituted of an
outer ring (white arrow) and a inner ring
(black arrow) (Fig. 2D, 2E). The three last
pictures (Fig. 2E, 2F and 2G) are
generated by averaging isolated needle
complexes (e.g: Fig 2D). Radial symmetry
can be implemented leading to Fig. 2G.
(Journet and Cornelis unpub l ished;
(Kubori et al., 1998); (Tamano  et al.,
2000); (Blocker et al., 2001) ; (Marlovits et
al., 2004)).
Figure 3: the Type three secretion system :
In vivo, the T3S system allows translocation of effector
proteins in one step into the eukaryotic cell from the
bacterial cytosol (Fig. 3A). The T3S apparatus (in gray)
spans the two bacterial membranes and connects the host
cell via a pore complex (in brown) inserted in the eukaryotic
plasma membrane. Effector proteins (in blue, yellow, or
green) can be injected directly into the eukaryotic cytosol.
Translocation is triggered by contact with the host cell. This
stimulus can be artificially substituted in vitro (e.g. Low
calcium concentration in Yersinia, Congo Red in Shigella,
high salt concentration in Sa lmone l l a ). Effectors,
translocators and some apparatus subunits are then
released in the external milieu (Fig 3B). Some substrates of
the T3S require the assistance of T3S chaperones (in red)
to be exported.
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Chaperonins and other chaperones:
The common definition of a chaperone is an adult person who accompanies one or more young,
unmarried individuals during social occasions, in order to prevent inappropriate social
interactions or illegal behavior. Even though the biological definition of chaperones applies to
proteins, the concept is identical : Chaperones are proteins interacting transiently with one or
several substrate, in order to prevent incorrect or premature intra- or inter-molecular
interactions. Chaperones are not involved in the final function of their substrate.
The concept of chaperone appeared with the discovery and the characterization of the “heat
shock proteins” (Hsp) by: Horwich AL, Neupert W and Hartl FU. In prokaryotes like E. coli, many
of these proteins are highly expressed under stress conditions, for example high temperature.
For this reason, the term “heat shock protein” has been used for many of them. According to
their guiding role regarding protein folding and protein-protein interactions, they were called
chaperones (or chaperonins). Chaperones associate with newly synthesized proteins that
cannot fold by themselves (Fig. 4). There are many different families of chaperones in
prokaryotes and in eukaryotes. Each family acts to aid protein folding in a different way.
Figure 4 : General outline of protein folding into a cell :
A newly synthesized protein, still associated with ribosome or already released, faces several
competing pathways. To achieve proper folding, they can undergo spontaneous folding, or
associate with chaperones. It is likely that in the absence of chaperones, aggregation or other
forms of misfolding would be the major pathways for many proteins.
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Heat shock proteins (or chaperonins):
Hsp60 (called GroEL/GroES complex in E. coli) is the best characterized large (~ 1 MDa)
chaperone complex (Fig. 5A). GroEL is a double 14mer ring, with a hydrophobic patch at each
two openings. GroES is a single-ring heptamer that binds to GroEL. GroEL/GroES may not be
able to undo previous aggregation, but it does compete against other proteins in the pathway of
misfolding and aggregation. Non-folded polypeptide is accepted within one of the GroEL
complex chamber and associates to the cavity walls via hydrophobic interactions (Figure 5B).
The cavity is so large that it can accommodate a native folded GFP of 54-kDa in its lumen.
GroES caps this structure triggering conformational changes that dislocate the hydrophobic
surface away from the cavity walls and release the polypeptide into the sequestered space,
triggering folding. This phase is ended by ATP hydrolysis; the affinity of GroEL for GroES is
weakened preparing the complex for the release of the folded polypeptide. The entrance of a
polypeptide in the opposite chamber triggers allosteric changes. These cause the dissociation
of GroES from GroEL and the release of the substrate into solution (Fenton and Horwich, 2003).
Hsp70 (DnaK in E. coli) is perhaps the best characterized small (~ 70 kDa) chaperonin. The
Hsp70 proteins are helped by Hsp40 proteins (DnaJ in E. coli), which increase the ATP
consumption rate and activity of the Hsp70s. Increased expression of Hsp70 proteins in a cell
results in a decreased tendency towards apoptosis. Although a precise mechanism has yet to
be determined, it is known that Hsp70's have a high-affinity for unfolded proteins when bound to
ADP, and a low-affinity when bound to ATP. It is thought that many Hsp70s crowd around an
unfolded substrate, stabilizing it and preventing its aggregation until it is properly folded. Then
the Hsp70s lose affinity and diffuse away (Mayer and Bukau, 2005).
                                 
Figure 5A : GroEL structure. GroEL is a large double 14mer ring (Fig. 5A). Subunits are colored in red,
orange or yellow (the four subunits at the back of the view are not visible). A GroES heptamer (in green)
closes the GroEL cavity, capping the top of the complex.
I. Introduction: Chaperonins and other chaperones
8
The SecB chaperone:
The SecB chaperone is a small (17 kDa) cytosolic protein of the Sec pathway. In Gram-negative
bacteria, periplasmic and outer membrane proteins are synthesized in the cytosol as precursor
proteins (preproteins) that contain a N-terminal signal sequence. The Sec pathway translocates
these preproteins across the cytoplasic membrane (Fig. 6B) (Driessen, 2001). Once a major
portion of the nascent preprotein has emerged from the ribosome (~150 aa), it is recognized by
SecB homotetramers (Fig. 6A). The nascent polypeptide associates through hydrophobic and
electrostatic interactions within a deep cleft at the surface of the chaperone multimer. In this
way, SecB maintains the preprotein in a translocation-competent state, by preventing intra- or
intermolecular interactions of the chaperone-covered domains. The complex is targeted to
SecA, the peripheral ATPase subunit of the translocase. SecA initiates the translocation of the
preprotein through the SecYEG translocon and SecB is then released.
Figure 5B : The GroEL–GroES reaction pathway. (a) A non-native polypeptide (solid wavy line) binds to
an asymmetric GroEL–GroES complex, the most likely acceptor state in vivo. It associates with the cavity
walls of the open upper chamber, specifically with exposed hydrophobic side-chains of the apical domains.
(b) GroES (in shaded gray) binds to the same ring as the non-native polypeptide, in the presence of ATP.
Then, conformational changes liberate the polypeptide into the sequestered space, triggering folding.
Folding proceeds in the upper chamber. This phase is ended by ATP hydrolysis (c). The affinity of GroEL
for GroES is weakened preparing the upper  ring complex for the release of its ligands. (d) When ATP and
another non-native polypeptide molecule bind into the lower chamber, allosterical changes trigger
dissociation of the ligands from the opposite (upper) chamber, discharging the substrate into solution. (e)
The released substrate either has reached the native state (N) or one committed to it (Ic) or is still in a
non-native state (I) that can bind to another GroEL molecule for a further attempt at folding.
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Figure 6 : The SecB chaperone, structure and mechanism :
A. Ribbon drawing of the SecB tetramer (based on the coordinates deposited to the Protein Data Bank as
1FX3. Each subunit in the tetramer is shown in a different color (1).
B. The proposed peptide-binding sites on SecB (according to Xu, Z. et al., 2000). The solvent-accessible
surface of SecB is colored based on the polarity of the underlying amino acids: all non-charged polar and
charged side-chains, green; all hydrophobic side chains (except tryptophan), yellow; all backbone atoms,
white. The conserved tryptophan residue is shown in blue. The drawing in (2) is the same orientation as in
(1) and is rotated by 90° towards the horizontal axis to show the peptide-binding channels on each side of
the tetramer. The channels are indicated with a white dot.
C. A possible mechanism of SecB-mediated targeting of preproteins to the translocase (adapted from
Driessen, A.J. 2000). Cytosolic SecB binds to the mature domain of a nascent preprotein (1), and
stabilizes its unfolded state (2). The SecB–preprotein complex is targeted to the SecYEG-bound SecA (3).
Targeting requires the high-affinity binding of SecB to the carboxyl terminus of SecA. Binding of the signal
sequence to SecA tightens the SecB–SecA interaction and elicits the release of the preprotein from SecB-
bound state with the concomitant transfer to SecA (4). Upon the binding of ATP by SecA, the preprotein
translocation is initiated and SecB is released from the ternary complex (5).
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The periplasmic chaperone PapD:
PapD is a 28.5kDa protein involved in the P pilus (Type 1 pilus) biogenesis. P pili are members
of a large family of surface organelles involved in bacterial adhesion (Sauer et al., 2000). P pili
are composed of six structural proteins that interact to form a composite fiber with two
subassemblies: a pilus rod formed by PapA subunits, and a thin fibrillum comprised primarily of
PapE subunits arranged in an open helical configuration. The pilus subunits are synthesized in
the cytoplasm of the bacteria and exported into the periplasm through the Sec pathway. There
the nascent subunits associate with the PapD chaperone in stable complexes by donor strand
complementation (Fig. 7A). The chaperone remains bound to the folded subunit, stabilizing and
capping its interactive surfaces, preventing premature polymerization, or aggregation in the
periplasm. Chaperone-subunit complexes are specifically targeted to the usher (Fig. 7B).
Figure 7A : Structure of the PapD
chaperone in complex with PapK.
The chaperone PapD (in blue) binds other
pilus subunits (here PapK in rainbow colors)
by donor strand complementation. The
chaperone completes the Ig fold of the
subunit by giving its G1 strand. This
interaction allows subunit folding and
prevents subunits aggregation and premature
polymerization.
Figure 7B : The PapD chaperone and the
P pilus biogenesis.
The Pap subunits of the pilus are
translocated into the periplasm via the Sec
pathway. The PapD chaperone associate
with the nascent subunits in the periplasm
(1). The chaperone-subunit complexes are
then targeted to the outer membrane pore
called the usher (PapC) (2). There, the N-
terminus of an incoming subunit displaces
the G1 strand of the chaperone in the most
recently assembled chaperone subunit
complex at the usher gate, leading to
polymerization (3). The chaperone-adhesin
complex (PapD-PapG) has a higher affinity to
the usher, initiating the pilus assembly.
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The usher is composed of PapC subunits and forms an outer membrane protein pore large
enough to allow the passage of pilus subunits. In the fim and pap systems, it has been shown
that the chaperone-adhesin complex binds with a higher affinity to the usher. This process is
thought set a hierarchy to initiate the pilus assembly. Formation of a chaperone-adhesin-usher
ternary complex induces a conformational change in the usher to an assembly-competent form
that is maintained throughout pilus assembly. The usher facilitates chaperone uncapping to
expose the interactive surfaces on the subunits that drive their assembly into the pilus.
I. Introduction: Chaperonins and other chaperones
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Discovery of the T3S chaperones:
In the early days of the T3S characterisation, Forsberg A. and Wolf-Watz H. identified a small
open reading frame (orf) upstream from the effector gene yopE. This orf, conserved in all three
pathogenic Yersinia species (Y.pestis, Y.pseudotuberculosis and Y.enterocolitica), encoded a
small protein of 130 amino acids. Insertion mutants were generated to knock out this gene.
They were tested for their ability to secrete proteins in the external milieu (in vitro type three
secretion in absence of calcium) and their virulence in mouse was evaluated. YopE was
secreted to a lower extend in the insertion mutant than in the wild type. As well, the virulence in
mouse was abolished (Forsberg and Wolf-Watz, 1990). As the secretion of the YopE protein by
the mutant bacteria was decreased, the authors concluded that the gene encoded upstream
yopE could encode a regulator. They subsequently called this gene: yerA, for yopE regulating
gene A.
In 1993, Wattiau and Cornelis studied the counterpart of yerA in Y.enterocolitica : sycE. They
demonstrated that if SycE has a influence on the production of YopE, it was at the post-
transcriptional level. Indeed using a yopE-lacZ reporter gene assay, the authors showed that
the level of yopE transcription was not affected when sycE was mutated (Wattiau and Cornelis,
1993). Apparently the lack of SycE affected more the secretion of YopE than its production in
the cell. By overlay, they demonstrated the direct binding of the SycE protein to YopE in a
specific manner. With these observations, the authors raised a new concept in the T3S.
Accordingly, by binding YopE, SycE could help to target the complex to the secretion apparatus,
prevent YopE folding and protect YopE from aggregation or proteolytic degradation. This
strongly reminds the function of more general chaperones like SecB or PapD. The authors
subsequently named the protein SycE for Specific YopE chaperone instead of YerA.
In addition to the new concept, this work also revealed some characteristics of the T3S effector
chaperone. The authors determined that SycE is cytosolic and that it binds to the N-terminal
part (98 first amino acids) of the effector. They also determined the apparent molecular mass of
purified SycE by size exclusion chromatography: slightly above 30 kDa, suggesting a dimeric
organization.
As the influence of SycE is limited to YopE, some other specific chaperones should have been
found for other secreted Yop proteins. Indeed, these first assumptions, and the notion of T3S
chaperone were reinforced in 1994 by the following discovery and the study of similar proteins.
Wattiau et al. presented the characterization of SycH and SycD playing an identical role with
YopH, and YopB and D (Wattiau et al., 1994).
Meanwhile, Ménard et al. revealed the existence of an equivalent protein in Shigella. IpgC a
small protein of 17kDa is required for bacterial entry into epithelial cells. Further investigations
showed that IpgC could bind independently to the translocators IpaB or IpaC. IpgC was required
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to stabilize IpaB and to prevent proteolytic degradation of IpaC (Menard et al., 1994). The
functional analogy between these T3S proteins and other chaperones was then well
established.
On this background started the intensive study of the T3S chaperones. Nowadays, even though
their structure and the way they interact with their substrate are well characterized, the main
function of T3S chaperones remains a matter of controversy.
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Characterization of T3S chaperones:
Classes of T3S chaperones:
According to the nature of the substrate they bind, chaperones have been sorted in three major
classes (Parsot et al., 2003). Class I chaperones are committed to one (Class IA) or more
(Class IB) effectors proteins. Class II chaperones are dedicated to the translocators and Class
III chaperones to the apparatus subunits of the T3S (Table 1). The organization in three classes
based on chaperones substrate may appear arbitrary. However, as presented in this chapter,
recent structural data show that the different chaperone classes correlates with different
chaperone structures.
Common traits of T3S chaperones:
Even though their primary sequence is not conserved, T3S chaperones share a number of
characteristic properties. They have a small size; their MW is ranging from 14 to 19 kDa. They
have an acidic pI, between 4 and 5 (with few exceptions). T3S chaperones are cytosolic
proteins; they are not exported. Except a few exceptions in the Class IB all T3S chaperones
have substrate specificity (one or two substrates only). Class I chaperones arrange in dimers
and present a typical C-terminal amphipathic α-helix.
Genetical environment of T3S chaperones:
T3S chaperones genes are generally included in the set of virulence genes on pathogenicity
islands, or virulence plasmids. Usually, they are encoded adjacently to their cognate effector
gene, however this is not an absolute rule. One could imagine that the close co-expression
could be important in the process of binding between the two partners, and for the protective
role of the chaperone. But, some chaperone genes are located far away from the gene
encoding their substrate. In Y.pseudotuberculosis, the consequence of an inversion event
brought sycH ~20kb away from yopH on the 70kb virulence plasmid. In addition more recent
studies revealed that some of the T3S chaperones are able to bind and assist two or more
different substrates (e.g. Spa15) (Page et al., 2002), sometimes not even encoded on the same
pathogenicity island (e.g. InvB) (Ehrbar et al., 2003).
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Table 1 : Representative T3S Chaperones of the different classes:
Class IA :
Organism Chaperone
Size
(aa)
pI Substrate Crystal structure
Membrane localization
of the Effector
EPEC CesF 127 4.2 EspF No  (Mitochondrial)
Salmonella SicP(SPI-I) 116 3.9 SptP Yes (in complex) Yes
Salmonella SigE(SPI-I) 113 3.9 SopB (SigD) Yes Yes
Salmonella SscB (SPI-II) 144 5.1 SseF No Yes
Shigella IpgE 120 4.0 IpgD No Not shown
Shigella IpgA 129 4.8 IcsB No Not shown
Yersinia SycE 130 4.5 YopE Yes (in complex) Yes
Yersinia SycH 143 4.8 YopH Yes (in complex) (Focal adhesion)
Yersinia SycN 123 5.1 YopN Yes (in complex) Not shown
Yersinia SycO 155 4.7 YopO No Yes
Yersinia SycT 130 4.4 YopT Yes Yes
Yersinia YscB 137 9.3 YopN Yes (in complex) Not shown
Class IB :
EPEC CesT 156 4.3 Tir, Map Yes Yes (Tir), Mitochondrial
membrane (Map)
Salmonella InvB 135 4.4 SopA, SopE,
SopE2, SipA (SspA)
Yes (SipA complex) Yes (SopE, SopE2, SipA)
Shigella Spa15 133 4.2 IpaA, IpgB1, OspC3,
OspB
Yes Yes (IpaA)
Class II :
Organism Chaperone
Size
(aa)
pI Substrate Crystal structure
EPEC CesD 151 7.4 EspB, EspD No
Pseudomonas PcrH 167 4.6 PopB, PopD No
Salmonella SicA (SPI-I) 165 4.6 SipB, SipC No
Salmonella SscA (SPI-II) 157 8.0 SseC, SseD No
Shigella IpgC 155 4.4 IpaB, IpaC No
Yersinia SycD 168 4.5 YopB, YopD No
Class III :
Organism Chaperone
Size
(aa)
pI Substrate Crystal structure
EPEC CesA 107 9.5 EspA Yes (in complex)
Pseudomonas ( ?) PscE 67 6.1 PscF No
Yersinia (?) YscE 66 6.7 YscF Yes
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Structure of T3S chaperones and complexes :
The structure of many different chaperones has been solved but not in all Classes. The Class I
chaperones was intensively studied with about 10 structures resolved. In the Class III, only a
few chaperones were crystallized, and their structure appeared to be completely different from
the Class I folding. Finally, very little is known about Class II chaperones, with no
crystallographic data available so far.
Class I chaperones : Chaperones of the effectors
The primary sequence of T3S chaperone is very variable. However, in Class I the secondary
structure is surprisingly well conserved, composed of three α-helices and five β-strands with the
following topology: α1β1β2β3α2β4β5α3 (Fig. 8) (Birtalan and Ghosh, 2001); (Stebbins and Galan,
2001); (Luo et al., 2001); (Birtalan et al., 2002); (van Eerde et al., 2004); (Buttner et al., 2005).
At the three-dimensional level, the folding of the Class I chaperone is conserved through the
different T3S systems (Fig. 9).
Class I chaperones associate in dimer via the central α-helix (α2) and the adjacent β-strands.
This interaction is mainly mediated by hydrophobic residues. So far this organization by pair
seems to be conserved among the Class I chaperones. Even in the case of Spa15, where the
Figure 8 : Class I chaperones have a conserved secondary structure.
The topology of Class I chaperone is conserved. The secondary structure is composed of three α-
helices (rectangles) and five β-strands (arrows). Class I chaperones associates in dimers mainly via
the α2 helices.
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orientation of the dimer subunits is tilted from 30°, the overall arrangement is similar.
Complexes are homodimeric, but a heterodimeric complex, SycN-YscB the chaperones of
YopN, has also been described (Jackson et al., 1998); (Day and Plano, 1998). However, the
folding and the heterodimer arrangement is canonical (Schubot et al., 2005).
Figure 9 : Three dimensional structure of Class I
chaperones.
Overall structure of Class I chaperones, each monomer is
represented in red or blue. Associated chaperones binding
domains or substrates are shown in green. A rotation
towards the horizontal axis provides a bottom view and
reveals the horse shoe like configuration of the chaperone
binding domain round the dimer (part of YopN has been
shaded in gray to distinguish its CBD around the SycN-YscB
dimer). Structures are from the PDB, references: SigE
1K3S, SycT 2BSJ, Spa15 1RY9, SycE-YopE 1L2W, SicP-
SptP 1JYO, SycN-YscB-YopN 1XKP, InvB-SipA 2FM8.
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Class I chaperones are known to bind their cognate effector in N-term, roughly within the 100
first amino-acids, downstream from the N-terminal secretion signal (Wattiau and Cornelis,
1993); (Woestyn et al., 1996); (Fu and Galan, 1998); (Jackson et al., 1998); (Lee and Galan,
2003); (Buttner et al., 2005); (Lilic et al., 2006); (Letzelter et al., 2006). These interaction
domains, called Chaperone Binding Domains (CBDs), have been delineated using various
methods: pull-downs, limited proteolysis, or have been deduced from structural data. In
association with the chaperones, those domains are poorly folded (Fig. 9) (Stebbins and Galan,
2001); (Birtalan et al., 2002); (Schubot et al., 2005); (Lilic et al., 2006). Mostly extended, with
few short α-helical or β-strand structure, they wrap around the chaperone dimer in a horseshoe-
like conformation. Crystal structures of chaperones, bound together with the CBD of their
cognate effector, revealed the nature of the interactions leading to the substrate recognition.
Hydrophobic patches and charges exposed at the surface of Class I dimers mediate the binding
to the effector via hydrophobic interactions (Stebbins and Galan, 2001); (Birtalan et al., 2002);
(Schubot et al., 2005); (Lilic et al., 2006). Many hydrogen bounds can also occur at the surface
of the dimer and their distribution is variable from one chaperone to another. The distribution of
the hydrophobic patches, and charges at the surface of the dimer constitute the determinants of
the binding specificity to the CBD. The crystal structure of SipA-InvB complex by Lilic et al,
revealed the existence of a conserved binding motif in the N-terminal part of the effectors. This
domain, called β-motif by the authors, binds one of the hydrophobic patches described earlier
by Birtalan et al. (Birtalan et al., 2002). This patch was renamed there as: “binding pocket”. The
interaction between those two domains (β-motif - binding pocket) appears to be crucial in order
to have a stable chaperone-substrate complex (Lilic et al., 2006).
Class II chaperones : Chaperones of the translocators
The structure and the organization of the translocator chaperones is still unknown. Only a few
data have been collected and no crystal structure has been resolved so far. Nevertheless Pallen
et al. noticed the presence of tetratricopeptide repeats (TPRs) in the Class II chaperones
(Pallen et al., 2003). These motifs discovered in eukaryotes are protein-protein interaction
modules consisting in a degenerated 34 residues repeat often arranged in tandem. Structurally,
they fold in a continuum of adjacent α-helices, forming a peptide binding groove. Usually
involved in protein-protein interaction, they are found in chaperone complexes involving Hsp70
and Hsp90. There, proteins like STI1, Cyp40 and Tom70 use TPRs to bind to the heat shock
proteins. The structure of Class II chaperones would then differ from the common α-β folding of
the Class I. A three dimensional modeling of SycD in complex with part of the amphipatic helix
of YopD (residues 280 to 292) has been performed to illustrate YopD fitting in the binding
groove (Pallen et al., 2003). Studies by Edqvist et al. allowed to identify two different interaction
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surface on the putative all α-helical structure of SycD, one interacting with YopB, one with YopD
(Fig. 10) (Edqvist et al., 2006). All these results and models would fit with the fact that SycD can
bind individually to YopB or YopD. Moreover, as YopB and YopD have multiple chaperone
interaction sites, the chaperone structure and the binding mode could be different from the one
observed for the Class I chaperones. Accordingly, Schmid et al. showed by circular dichroism
the α-helical nature of SycD (Schmid et al., 2006). They also demonstrated by gel filtration and
crosslinking that purified SycD could dimerize, like the Class I chaperones. The resolution of
Class II chaperones structure would be helpful to bring some light on the situation.
Figure 10 : Three dimensional model of the Class II chaperones SycD.
Model of SycD/LcrH structure based on the study of tetratricopeptide repeats (Edqvist et al.
2006). The structure is all α-helical. The residues with phenotypes affecting binding or
secretion of substrates are highlighted in the structural model. Those with extensive side chains
are depicted in stick format, while those with small side chains that project towards the concave
surface of the theoretical structure are shown in space-filling format. In this structural model,
residues on the outside of the molecule with phenotypes affecting binding or secretion of YopD
are highlighted in blue, while residues in the binding groove with phenotypes affecting binding
or secretion of YopB are highlighted in red. The two groups of residues clearly fall on alternate
faces of the protein in the structural model.
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Class III chaperones : Chaperones of the T3S apparatus subunits
For a long time the only data available about Class III chaperones were coming form the
flagellar field. As mentioned already, flagellum and T3S are evolutionarily linked and their basal
body share strong structural similarities. Flagellar subunits are also secreted via a T3S pathway.
Proteins like FlgN interacting with hook associated proteins (FlgK and FlgL), or FliT preventing
the oligomerization of the filament cap subunits (FliD) can be considered as chaperones (Fraser
et al., 1999). FliS the chaperone associated with the filament subunits (FliC) was proposed to
prevent intracellular polymerisation (Auvray et al., 2001); (Evdokimov et al., 2003). FliS has a
compact all α-helical structure, different from the Class I chaperones and the Class II
chaperones (Evdokimov et al., 2003). FliS was shown to form a dimer, alone or in complex with
FliC (Auvray et al., 2001). However according to another study (Muskotal et al., 2006), and the
crystal structure resolved by Evdokimov et al. , FliS is monomeric and binds FliC in a 1:1 ratio.
The C-terminal binding domain of FliC (residues 479-518) wraps around the chaperone (Fig.
11), with slightly stretched, but still significant secondary structure. Hydrophobic interactions are
also the key of the association between the two proteins.
Beside the flagellar protein, only one Class III chaperone structure has been determined: CesA
has been crystallized with its substrate EspA, the T3S filament subunit of enteropathogenic
E.Coli (EPEC) (Yip et al., 2005). CesA adopts an elongated all α-helical structure, with an
overall hairpin shape (Fig. 11). The inner residues facing this structure are mainly non polar,
generating a hydrophobic groove allowing EspA binding. Two long α-helices, N-terminal (31-59)
and C-terminal (148-190) constitute the chaperone binding site of the filament subunit. This four
helices structure of the CesA-EspA complex, is quite peculiar compared to the Flis-FliC
complex.
No more identified Class III chaperone has been crystallized so far. However, the structure of
other T3S components is already determined and can be compared to the structures of the
CesA-EspA complex. EspA interacts with its chaperone via two antiparallel α-helices (Fig. 11).
Comparable antiparallel α-helices are found in the structure of the needle subunits of
Burkholderia and Shigella (Fig. 12). No Class III chaperone has been identified so far for these
compounds. However, the needle subunits of Pseudomonas (PscF) or Yersinia (YscF) are
interacting with other proteins in the cytosol of the bacteria, PscE and YscE respectively, and
are significant chaperone candidates (Quinaud et al., 2005); Sorg and Cornelis, unpublished).
Interestingly, the structure of YscE and CesA are fairly similar (Fig. 12).
Identification and characterization of other Class III chaperones as well as future
crystallographic studies will allow to determine whether Class III chaperones encloses proteins
with heterogeneous structures (E.g. FliS, CesA) or if the structural differences state between the
flagellar chaperones and the T3S apparatus chaperones. New insight on this family of proteins
will maybe lead to a new classification.
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Figure 11 : Three dimensional structure of the Class III chaperones FliS And CesA:
The structure of the Class III chaperones with their substrate (FliS-FliC and CesA-EspA) is compared to
the structure of YopE bound to SycE (Class I chaperone). The structure of the Class III chaperones is all
α-helical. Chaperones are in blue and substrates are in red. YopE and FliC are binding their chaperones
in an extended conformation. In a different way, CesA binds the N-terminal and C-terminal α-helices of
EspA.
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About chaperone classes…
The sorting of chaperones into three classes has been established by Parsot et al. (Parsot et
al., 2003). This proposition, is based on the kind of substrate chaperone are associated (I
Effectors, II Translocators, III Apparatus subunits) and can appear arbitrary. Initially,
characteristics like molecular weight, pI, genetical location, suggested all T3S chaperones to be
similar. Crystallographic data, showed that T3S chaperones present a structural diversity
between the three classes. The Class I is from far the best characterized with over 10 structures
resolved. Although the primary sequence varies a lot from one Class I chaperone to another,
the three dimensional structure of the proteins within this class is remarkably well conserved.
This structure made of three α-helices and five β-strands is completely different from the all α-
helical structure of the Class III. Indeed, chaperones of the different classes appear to be from
different structural families.
Only a few chaperones from the Class III were crystallized so far. The chaperones of the
flagellum were initially considered as elements of the Class III. FliS was the first one to be
crystallized with its substrate FliC (the flagellar filament subunit) (Evdokimov et al., 2003). The
flagellum and the T3S system derive probably from a common ancestor. But the similarities
between the two systems are limited to the basal body. Therefore the link between FliS, the
chaperone of the filament subunit -a distal element of the structure- and the Class III is arguable
and would explain such a singular structure. The structure of EPEC T3S filament subunit EspA
in complex with the chaperone CesA brought new informations (Yip et al., 2005). As for FliS,
CesA presented an all α-helical structure. However, the difference between the two chaperone
structures is important, and could reflect the difference between two different systems
(Flagellum vs. T3S system). Accordingly the structure of YscE (Phan et al., 2005) a chaperone
candidate of YscF (the T3S needle subunit), is also different from the one from FliS, but the
overall shape is quite close to the one of CesA (Fig. 12). Structures of the chaperones within the
Class III could be similar, like chaperones structure within the Class I. This would lead to the
exclusion of the flagellum chaperones from the Class III. Another possibility would be that Class
III chaperones regroup a heterogeneous set of chaperones. Additional data are still missing to
consider the diversity of the Class III.
No crystallographic study has been made so far on Class II chaperones. The few data collected
from Pallen et al. propose a model in which the chaperones of the translocators would also
have an all α-helical structure (Pallen et al., 2003). This structure based on tetra-tricopetide
repeats would differ from the one observed in the Class III and the Class I. Therefore, the Class
III, the Class I and probably the Class II proteins are from different structural families. Future
resolution of other T3S elements will help to confirm or redefine the Classes of T3S chaperones
according to their structure.
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Figure 12 : The structure of the CesA-EspA complex is presented with several T3S apparatus
subunits and the putative chaperone YscE.
EspA is shown after rotation toward the horizontal axis. The antiparallel α-helices composed by the N-
terminal and C-terminal of EspA are involved in the binding to the chaperone CesA. These antiparallel
helices have some structural equivalents in the needle subunits of Burkholderia, Shigella and in the
Yersinia needle tip protein LcrV. The chaperone CesA has a similar structure to the chaperone candidate
YscE of Yersinia. Structures are from the PDB, references: 1XOU (EspA-CesA); 1ZWO (YscE); 2G0U
(Needle subunit Burkholderia); 1R6F (LcrV).
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Multiple functions of T3S chaperones:
T3S chaperones protect their substrate from premature intra- or inter-molecular interactions in
the bacteria, as chaperone are supposed to do. However, the role of T3S chaperones is not
restricted to this task and their influence on the system is far more complex. Some roles
proposed would derive directly from the chaperoning action; like storage and stabilization of
their partner, or acting as anti-folding factors, in order to maintain the substrate in a secretion
competent state. In addition, they seem to be involved at many different levels in the T3S
process, displaying versatile functions. From their central position in the T3S mechanism,
chaperones appear to have an effect on the hierarchy of secretion, on the regulation of the
secretion, on the secretion pathway specificity… T3S chaperones can be sorted in three
classes according to the nature of their structure and their properties. The three classes will be
described separately.
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Class I : Chaperones of the effectors
Storage and stabilization :
Many data have shown that chaperones help to stabilize their substrate. For instance, the
effectors YopE (SycE) (Frithz-Lindsten et al., 1995), SptP (SicP) (Fu and Galan, 1998), Tir
(CesT) (Abe et al., 1999), and IpgD (IpgE) (Niebuhr et al., 2000), are better expressed, or have
an extended life time in the bacterial cytosol when bound to their chaperone (under brackets).
However, this effect is not universal for Class I chaperones. Spa15, a multivalent chaperone of
Shigella, is required for the stability of IpgB1, but not for the one of IpaA, another of its
substrates (Page et al., 2002). Also, the intrabacterial stability of YopH is not affected by the
absence of SycH. The effector cannot be secreted by sycH deficient mutant bacteria and
accumulates in the cytosol (Wattiau et al., 1994). Other studies showed that although the
secretion of YopE was reduced in a sycE  mutant, the intracellular concentration was
approximately equivalent to the wild-type level (Wattiau and Cornelis, 1993). In this situation,
even if the stability is decreased, the pool available inside the bacterial cell seems to be similar.
Chaperones could also stabilize their substrate by preventing their aggregation. Without their
cognate chaperone, effectors like YopE (Birtalan et al., 2002), YopO, YopT (Letzelter et al.,
2006), SipA (Lilic et al., 2006) have a clear tendency to aggregate. In absence of their
chaperone, presynthesized proteins aggregate in the bacterial cytosol through their CBD. This
aggregated state is incompatible with export. By preventing aggregation to occur, chaperones
keep their substrate soluble and fit for export. Indeed, stored proteins require their chaperone to
be exported. In Shigella, presynthesized IpaA can be secreted only in presence of its chaperone
(Page et al., 2002). In Yersinia, the translocation of YopE after protein synthesis inhibition is
also chaperone dependent (Lloyd et al., 2001).
Secretion and translocation : Chaperones as targeting factors :
Chaperone knockouts usually fail to export their substrate efficiently. In vitro, some effectors
lacking their cognate chaperone are less secreted. Moreover, during cell infection, they are not
translocated in the eukaryotic cell. To explain the export deficiency in chaperone mutants, other
hypotheses than the consequence of CBD aggregation in the bacteria have been proposed. For
instance, chaperones would facilitate the recognition of the substrate by the T3S apparatus and
play a targeting role (Fig. 13). The effector YopE with a frameshifted secretion signal, is
exported by the wild-type, but not by the mutant lacking the SycE chaperone (Lloyd et al.,
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2001); (Cheng et al., 1997). Without the export signal, targeting of the effector to the T3S
apparatus would be mediated by the chaperone. Recently, Akeda and Galan showed that InvC,
the Salmonella SPI-1 ATPase is involved in substrate recognition. A direct interaction between
effector-chaperones complex and the ATPase of the T3S system has been demonstrated
(Akeda and Galan, 2005). The N-terminal part of the effector, or the chaperone alone was
shown to bind InvC. Thus, chaperones could participate in the targeting, by binding and
presenting the substrate to the T3S ATPase (Fig. 13).
Structural analysis of effector-chaperones complexes also suggested a role in substrate delivery
to the T3S. By binding immediately downstream from the export signal, chaperones could keep
the N-terminal signal exposed, preventing its folding within the structure. A “three-dimensional
secretion signal” has been proposed (Birtalan et al., 2002), but the structure of new chaperone-
effector complexes (Schubot et al., 2005); (Lilic et al., 2006) revealed quite some diversity in the
effector chaperone binding domain path around the chaperone dimer. This observation
weakened the idea of a conserved overall structure constituting a three-dimensional secretion
signal (Lilic et al., 2006).
                   
Figure 13 : Targeting functions of the Class I Chaperones.
a. Chaperones prevent the folding of the secretion signal within the structure, or the aggregation of
effectors. The secretion signal is maintained exposed and the effector soluble.
b. Chaperones present effectors with a defect in their secretion signal to the secretion apparatus.
Chaperones-effector complexes interact with the ATPase and mediate the recognition.
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Another implication of the chaperones in targeting has been proposed by Lee and Galan (Lee
and Galan, 2004). In absence of their chaperone binding domains, SptPΔ35-61 and SopEΔ39-77 are
secreted via the flagellum apparatus, but not via the T3S machinery anymore. The SptP1-35 -
PhoA fusion can also be secreted by the flagellum. The authors proposed that the N-terminal
part of the effector would contain an ancestral secretion signal common to both apparatus. The
presence of the chaperone binding domain and the binding of the chaperone would confer the
T3S pathway specificity to the effector protein. However, monitoring internalization of
Salmonella into cells, SopEΔ39-77 cannot complement a SopE loss-of-function mutation,
indicating that even though it was secreted, it cannot be translocated into host cells via the
flagellar apparatus. Similar investigations were performed by Ehrbar et al., testing different
SopE mutants with poly-alanine replacement in the chaperone binding domain (Ehrbar et al.,
2006). Mutants able to bind the InvB chaperone are secreted in a T3S dependent manner and
can be delivered into host cells via the T3S apparatus. Mutants unable to bind InvB are
secreted through the flagellum, but not translocated.
The chaperone pathway specificity observed in Salmonella is probably not applicable to all the
T3S. In Yersinia, the effector YopO is secreted with or without its chaperone binding domain, in
a T3S dependent manner (Letzelter et al., 2006). Moreover, YopE or YopO lacking their
chaperone binding domain are maybe not delivered into host cells when expressed in a wild-
type bacteria, but can be translocated by multi- effector deficient bacteria, excluding any
flagellar pathway (Boyd et al., 2000), (Letzelter et al., 2006). Therefore the signal for T3S
targeting does not involve the chaperone binding domain and the chaperone. Effector and
chaperone would have co-evolved, to optimize the recognition and the uptake by the T3S
apparatus. The determinant of the T3S signal would still be present in the N-terminal signal
sequence, however the presence of the chaperone would support the effector uptake. Indeed,
in this background, effectors like YopE15-Cya, YopEΔ17-77 or YopOΔ20-77-Cya with a signal
sequence, but without their chaperone binding domain are still translocated (Boyd et al., 2000),
(Letzelter et al., 2006). However they cannot compete against the other Yops in an optimized
process like the wild type T3S. Subsequently, Class I chaperone have been proposed to play a
derivative of targeting function, by helping to compete against other substrates and optimizing
their delivery.
Antifolding, unfolding factors :
Given the size of the inner diameter of the T3S needle, proteins cannot be exported in a folded
way (Blocker et al., 2001); (Feldman et al., 2002). After the resolution of the SicP-SptP complex
structure, Stebbins and Galan proposed that chaperone could keep their substrate unfolded in a
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secretion competent state (Stebbins and Galan, 2001). The resolution of new complexes with
full length substrate like YscB-SycN-YopN (Schubot et al., 2005), or InvB-SipA (Lilic et al.,
2006) revealed that Class I chaperones only maintain a discrete N-terminal CBD unfolded.
Other experiment evaluating the catalytic activity of YopE (Birtalan et al., 2002), YopH
(Neumayer et al., 2004), YopO (Letzelter et al., 2006) bound to their chaperone revealed a
standard enzymatic activity, implying a correct folding of the enzymatic core. By maintaining the
N-terminal CBD unfolded, chaperones could facilitate the unfolding of the protein prior export by
the T3S, initializing the process mediated by the ATPase (Akeda and Galan, 2005).
Control, regulation and hierarchy of secretion :
In Yersinia, LcrQ/YscM1 is a regulator that exerts a negative feedback on the virulence genes
(Rimpilainen et al., 1992); (Stainier et al., 1997). LcrQ/YscM1 binds the Class I chaperone SycH
(Cambronne et al., 2000); (Phan et al., 2004). When the T3S apparatus is active, LcrQ/YscM1
is exported and its depletion in the bacteria lead to an “up-regulation” of the virulence genes
(Fig. 14). The over-expression of SycH has the same effect as the depletion of YscM in the
bacteria: the production of several T3S proteins is increased (Cambronne et al., 2000). Since
the export of LcrQ/YscM1 is SycH dependent, the Class I chaperone is involved in a way in this
regulation process.
Another study proposed that LcrQ/YscM1 could control the secretion activity directly at the level
of the T3S apparatus (Wulff-Strobel et al., 2002). Before activation of the T3S system, the
LcrQ/YscM1–SycH complex would interact with a hypothetical site on the apparatus. There the
LcrQ/YscM1–SycH complex is hypothesized to exert its down-regulation feedback. Upon
activation LcrQ/YscM1 would be first secreted. The release of LcrQ/YscM1 would leave SycH
free to associate with YopH. The presence of SycH directly on the apparatus would then
prioritize the secretion of YopH on the other Yops. SycH would then be involved in the
regulation process by setting a hierarchy in substrate secretion. No additional data came so far
to support this hypothesis.
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Figure 14 : Chaperones involved in the control of the export activity.
The Class I chaperone SycH can bind its cognate effector YopH, as well as the LcrQ/YscM.
LcrQ/YscM exert a negative feedback on the transcription of virulence proteins (a). When secretion
is active, LcrQ/YscM is exported releasing the negative feedback inside the cell (b). The secretion of
LcrQ/YscM is strictly SycH dependent, involving the chaperone in the process (c).
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Class II : Chaperones of the translocators
Storage and stabilisation:
In Shigella, the translocators IpaB and IpaC associate in a complex once exported into the
extra-cellular milieu (Menard et al., 1994). Each of them binds the Class II chaperone IpgC
individually. Both are degraded in the absence of IpgC in the bacterium. IpaB alone is unstable
due to two hydrophobic domains in the C-terminal part. Binding of the chaperone stabilizes this
substrate. On the other hand, IpaC is stably expressed in E.coli. Their common degradation in
ipgC mutants is due to the premature association of IpaB and IpaC in the cytosol. IpgC prevents
this event, allowing the storage of the two proteins (Menard et al., 1994). This observation is
common to several T3S systems. In Salmonella, SicA stabilizes and prevents the association of
the translocators SipB and SipC (Tucker and Galan, 2000), as well as PcrH with PopB and D in
Pseudomonas (Schoehn et al., 2003). In Yersinia, SycD fulfils the same function binding YopB
and D (Wattiau et al., 1994); (Neyt and Cornelis, 1999b). In addition, YopB is toxic when
expressed without SycD in E.coli (Neyt and Cornelis, 1999b). The protective role of the
chaperone would serve the protein YopB as well as the bacteria itself.
Control, regulation and hierarchy of secretion:
T3S genes are generally activated by transcriptional regulators from the AraC/XylS family. Upon
appropriate stimulus they activate transcription of the virulence genes. This activity can be
modulated by some elements of the T3S like chaperones. In Salmonella, Darwin and Miller
showed that InvF the T3S transcriptional regulator binds the Class II chaperone SicA. Both
proteins are required to activate the transcription of the sicA, sigD and sopE promoters of the
respective operons (Darwin and Miller, 2001); (Darwin and Miller, 2000). A similar
transcriptional regulation involving the Class II chaperone IpgC was found in Shigella (Mavris et
al., 2002). MxiE and IpgC, the respective counterparts of InvF and SicA, are involved in
transcription of the virA and ipaH genes. These genes are induced only when the secretion is
active. The Mxi-IpgC interaction sets a type of hierarchy in the secretion process. First, IpaB
and IpaC, the substrates of IpgC, are secreted. Next, free IpgC can bind MxiE and activate
transcription of the virA and ipaH genes (Fig. 15). Then, the second set of effector proteins (VirA
and IpaH) can be secreted. MixE alone is not able to activate the transcription and requires
IpgC as a co-factor. However, no direct interaction has been shown between the two proteins.
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Figure 15 : Regulation properties of the Class II chaperones.
In the cytosol, the Class II chaperone IpgC is associated with the translocators IpaB and IpaC. Once IpaB
and C are exported IpgC is released (a). Free IpgC can bind and activate the transcriptional activator MxiE
(b) initiating the transcription of the VirA and IpaH genes (c). A second set of effector is then synthesized
and can be exported (d).
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A recent study identified an additional partner for the secretion control in Shigella. OspD1 and
its chaperone Spa15 would play an anti-activator role, preventing the interaction of MxiE with
IpgC (Parsot et al., 2005). When the T3S system is inactive, IpaB and IpaC are associated
independently with IpgC, which prevents premature interactions between the two translocators
and titrates IpgC. OspD1 is associated with Spa15, which stabilizes OspD1 and probably
maintains it in a secretion competent state. MxiE is associated with the Spa15–OspD1 complex,
which both stabilizes MxiE and prevents it from being activated by IpgC. Upon T3S activation,
export of IpaB and IpaC liberates IpgC. However, this is not sufficient to activate MxiE as long
as OspD1 is present in the cytoplasm. If the TTS apparatus remains active, transit of OspD1
occurs, releasing MxiE. Then, MxiE can interact with IpgC and activate transcription. Thus, two
chaperones IpgC (Class II) and Spa15 (Class I) are involved in this regulation process.
In Yersinia, three out five genes of the translocator operon have an impact on the bacterial
growth in low calcium condition at 37°C. They were subsequently considered to encode
regulators (Bergman et al., 1991). The chaperone SycD is one of them and was initially called
LcrH for “Low calcium response H”. The deletion of sycD, or one its substrates gene yopD,
results in the same phenotype: the exported virulence proteins are constitutively produced. The
YopD-SycD complex was then identified as the regulator of the virulence gene expression
(Anderson et al., 2002); (Francis et al., 2001). Mutants unable to constitute a stable complex
loose their regulatory properties, they constitutively produce the virulence proteins. Thus, it was
proposed that the complex establishes the negative regulatory loop, rather than the chaperone
or the YopD translocator alone (Francis et al., 2001). This SycD-YopD complex has also been
shown to bind and contribute to the degradation of the yopQ mRNA, suggesting a post-
transcriptionnal regulation mechanism (Anderson et al., 2002).
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Class III : Chaperones of the T3S apparatus subunits
Storage and stabilisation:
Chaperones of the Class III are also involved in production and storage of their substrate. FliS is
a small acidic and cytoplasmic protein of the flagellum apparatus. It is required for the export of
FliC, the filament subunit of the flagellum (also called flagellin). In vitro, flagellar filaments can
grow from seeds (short pieces of flagellum) by addition of purified FliC. This polymerisation is
prevented by the presence of the chaperone FliS (Auvray et al., 2001); (Evdokimov et al.,
2003).
In T3S, several proteins have a similar behavior. Purified EspA (the subunit of the EPEC
filaments) forms filamentous polymers spontaneously. CesA forms a complex when co-
expressed with EspA. No filamentous structure appears in these conditions, suggesting that the
binding of CesA to EspA prevents polymerization. In Pseudomonas aeruginosa, PscE prevents
the polymerization of PscF, the needle subunit of T3S apparatus (Quinaud et al., 2005).
However PscG, a third protein takes place in the PscE-PscF complex. But so far, the precise
role of this protein is not known. The Yersinia homologues YscE, YscF and YscG act in a
identical way (Sorg and Cornelis unpublished).
LcrV, the protein forming the tip structure at the end of the T3S needle is functionally related to
EspA. The EspA filaments polymerize at the tip of the EspF needles. Although the Yersinia tip is
not a filamentous structure, LcrV forms a multimeric complex at the tip of the needle (Mueller et
al., 2005). LcrV is known to associate with LcrG, which could be a chaperone for LcrV. The idea
that LcrG prevents the oligomerization of LcrV has not been investigated.
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Final word:
One recurrent role of T3S chaperones is the stabilization of the substrate, allowing its storage
into the bacteria. According to their nature and their structure, T3S apparatus subunits require
the assistance of Class III chaperones into the cytosol in order neither to aggregate nor to
polymerize. As well, Class II chaperones protect the hydrophobic domains and the mutual
interaction of the translocators inside the bacteria. Other associated chaperone functions, such
as regulation, could have evolved later. For effectors the situation is a bit different as some do
have and need a chaperone and some other do not. Why?
The role of Class I chaperones could be to prevent aggregation of the effector, to present the
secretion signal to the apparatus or to keep it exposed… Actually to keep effectors in a
secretion competent state. So far, no chaperone binding domain has been shown to be part for
the catalytic core of its effector. So why a domain disturbing storage and secretion would still be
kept in a system, as well as an additional chaperone to prevent its negative side effects?
Effector can also be somehow targeted to the host cell without CBD and chaperone, when not
in “competition” with all the other effectors. Additionally, some effectors are working without
chaperone. Thus, could the CBD be required to fulfill a function, creating the need for a
chaperone?
II. Aim of the Thesis
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Aim of the thesis :
In all pathogenic Yersinia (Y.enterocolitica, Y.pseudotuberculosis, and Y.pestis), the open
reading frame ORF155 is located upstream of yopO and yopP. The putative product of this ORF
is small (17 kDa), has an acidic pI (4.5) and has a hydrophobic moment plot that resembles the
one of the Syc chaperones (Iriarte and Cornelis, 1999a). Therefore, it has the characteristics of
a T3S chaperone.
The aim of my thesis was to determine whether the product of ORF155 is a chaperone for
YopO and/or for YopP. Since the role of chaperones is still elusive, we investigated its exact
function.
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Research summary :
Several substrates of the T3S system require the assistance of small cytosolic chaperones to
be efficiently exported. There are three classes of T3S chaperones. Effector proteins are
assisted by Class I chaperones. Although Class I chaperones are well characterized, their main
function is still a matter of controversy.
In this thesis, we demonstrate that orf155 encodes a specific chaperone for the effector YopO
that we called SycO. We showed that SycO enhances YopO secretion in vitro and is required
for translocation of YopO into infected cells. By pulldown assay we demonstrated that residues
20 to 77 of YopO are required and sufficient for SycO binding. Using crosslinking experiments
and size exclusion chromatography analysis, we determined the stoichiometry of purified SycO
and YopO-SycO complex. SycO alone forms dimers in solution and the YopO-SycO complex
has a 1:2 stoichiometry. These results suggested that SycO is a typical chaperone of the Class
I.   
YopO is a serine/theronine kinase that interacts with Rho and Rac and disrupts the cytoskeleton
of the target cells. YopO has been shown to localize at the cell plasma-membrane. By
transfection of YopO-EGFP hybrid proteins into HEK293T cells, we demonstrated that the
chaperone binding domain (CBD) coincides with the membrane localization domain of YopO.
Nevertheless, the CBD was not needed for the kinase activity of YopO. By ultracentrifugation,
we also showed that the CBD causes YopO aggregation in the bacteria, when SycO does not
cover it. Further, we show that the CBD of YopE and YopT also caused aggregation in the
bacteria in the absence of SycE and SycT respectively. YopE, YopT and T3S effectors in other
systems also act at the membrane of the eukaryotic host cell.
We propose a new hypothesis concerning the role of T3S chaperones. The sub-cellular
localization domain of effectors is aggregation-prone and creates the need for a chaperone
inside bacteria. We propose that masking such aggregation-prone localization domains may be
a general function for type III effector chaperones.
Statement of my work :
Personal contribution to the article “The discovery of SycO highlights a new function for type III
effector chaperones”, Letzelter et al., 2006 : I generated all the pML constructs and performed
the experiments for figure 1a, 2, 3, 4, 5, 6, 7, supplementary material S2. I contributed to the
analysis of the data, I designed all the figures and participated in the writing of the manuscript.
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The discovery of SycO highlights a new function
for type III secretion effector chaperones
Michel Letzelter1, Isabel Sorg1, Luı´s Jaime
Mota1,3, Salome Meyer1, Jacqueline
Stalder1, Mario Feldman1,4, Marina Kuhn1,
Isabelle Callebaut2 and Guy R Cornelis1,*
1Biozentrum der Universita¨t Basel, Basel, Switzerland and
2De´partement de Biologie Structurale, Institut de Mine´ralogie et de
Physique des Milieux Condense´s (CNRS/UMR 7590) Universite´s Paris 6
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Bacterial injectisomes deliver effector proteins straight
into the cytosol of eukaryotic cells (type III secretion,
T3S). Many effectors are associated with a specific chaper-
one that remains inside the bacterium when the effector is
delivered. The structure of such chaperones and the way
they interact with their substrate is well characterized but
their main function remains elusive. Here, we describe
and characterize SycO, a new chaperone for the Yersinia
effector kinase YopO. The chaperone-binding domain
(CBD) within YopO coincides with the membrane localiza-
tion domain (MLD) targeting YopO to the host cell
membrane. The CBD/MLD causes intrabacterial YopO
insolubility and the binding of SycO prevents this insolu-
bility but not folding and activity of the kinase. Similarly,
SycE masks the MLD of YopE and SycT covers an aggrega-
tion-prone domain of YopT, presumably corresponding to
its MLD. Thus, SycO, SycE and most likely SycT mask,
inside the bacterium, a domain needed for proper localiza-
tion of their cognate effector in the host cell. We propose
that covering an MLD might be an essential function of
T3S effector chaperones.
The EMBO Journal (2006) 25, 3223–3233. doi:10.1038/
sj.emboj.7601202; Published online 22 June 2006
Subject Categories: microbiology & pathogens
Keywords: effectors; targeting; translocation; type III
secretion; Yops
Introduction
Type III secretion (T3S) allows pathogenic and symbiotic
Gram-negative bacteria to deliver bacterial effector proteins
straight into the cytosol of an eukaryotic host cell (Cornelis
and Wolf-Watz, 1997). Translocation of the effectors is a very
rapid process (Schlumberger et al, 2005) triggered by host cell
contact (Pettersson et al, 1996) and achieved in one step
by a sophisticated nanomachine called the injectisome or
needle complex (Kubori et al, 1998; Mueller et al, 2005).
The assembly and operation of the injectisome involves small
(12–18 kDa) chaperones that remain in the bacterial cytosol
(Wattiau and Cornelis, 1993; Menard et al, 1994; Feldman
and Cornelis, 2003; Parsot et al, 2003; Ghosh, 2004). These
chaperones represent a special family of chaperones found
only in T3S systems. Some of these chaperones are involved
in the assembly of the injectisome (class III) or the transloca-
tion pore (class II), whereas others are ancillary to effectors
(class I). Class-I chaperones are acidic (pI: 4–5), usually
dimeric, proteins, which bind their cognate effector within
their first 100 amino acids, just downstream of the short
N-terminal secretion signal. They are often, but not always,
encoded next to the gene encoding their partner protein. They
present a low sequence similarity, but their structure is quite
well conserved. Several three-dimensional structures of T3S
chaperones have been solved during the last years, showing
that they all adopt a similar fold consisting of five b-strands
and three a-helices (Birtalan and Ghosh, 2001; Luo et al,
2001; Stebbins and Galan, 2001; Evdokimov et al, 2002;
Trame and McKay, 2003; Phan et al, 2004; van Eerde et al,
2004; Buttner et al, 2005; Locher et al, 2005). Structures of
chaperones in complex with their effector proteins have
shown that the chaperone-binding domain (CBD) of effectors
wraps around the homodimers in an extended, horseshoe-
like conformation with some secondary structure organiza-
tion in a-helical structures (Stebbins and Galan, 2001;
Birtalan et al, 2002; Phan et al, 2004). Chaperones are
removed from effectors, before their translocation into host
cells, by the ATPase that is part of the injectisome (Woestyn
et al, 1994; Akeda and Galan, 2005). Although some chaper-
ones of T3S effectors have been intensively studied and
characterized, their essential function remains a matter of
controversy. Some studies suggest that chaperones could be
three-dimensional targeting factors or even that they play a
role in the setting of a secretion hierarchy (Boyd et al, 2000;
Birtalan et al, 2002). Other observations suggest that they
are required for the storage of effectors in the bacterial
cytosol before secretion (Page et al, 2002) and even that
they prevent folding during storage (Stebbins and Galan,
2001; Page et al, 2002).
The Ysc (for Yop Secretion) T3S system allows pathogenic
Yersinia (Y. pestis, Y. pseudotuberculosis and Y. enterocolitica)
to escape the innate immune defenses. It is encoded on
a 70-kb virulence plasmid, called pYV in Y. enterocolitica,
and it injects six effector proteins, called Yops, into the cytosol
of macrophages. YopH, YopE, YopT and YopO disturb the
cytoskeleton dynamics and inhibit phagocytosis (Cornelis,
2002). Three of these Yops, namely YopE, YopH and YopT,
have a dedicated chaperone called SycE (Wattiau and Cornelis,
1993; Birtalan and Ghosh, 2001), SycH (Wattiau et al, 1994;
Phan et al, 2004) and SycT (Iriarte and Cornelis, 1998; Buttner
et al, 2005; Locher et al, 2005), respectively. No chaperone has
been described so far for YopO (called YpkA in Y. pestis and
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Y. pseudotuberculosis), a broad-spectrum serine threonine
kinase (Galyov et al, 1993) that becomes activated upon
contact with actin (Juris et al, 2000). It is localized to the
plasma membrane of the target cell (Hakansson et al, 1996;
Dukuzumuremyi et al, 2000) and it interacts with Rho and
Rac (Barz et al, 2000) but its physiological target is still
unknown. The gene encoding YopO (YpkA) is part of an
operon encoding also the effector YopP (Cornelis et al, 1987;
Galyov et al, 1994; Iriarte and Cornelis, 1999) (YopJ in
Y. pestis and Y. pseudotuberculosis), which interrupts
pro-inflammatory signalling cascades and leads macrophages
to apoptosis (Mills et al, 1997; Zhou et al, 2005). The first
open reading frame of the operon, orf155, encodes a protein
that presents all the characteristics of a T3S chaperone (Iriarte
and Cornelis, 1999), but its role could not be demonstrated
so far (Trulzsch et al, 2003).
Here, we demonstrate that orf155 indeed encodes a
chaperone for YopO and we called it SycO. We show that
SycO prevents the intrabacterial aggregation of YopO by
covering a membrane localization domain (MLD). As many
T3S effectors, which have a chaperone, have also been shown
to be membrane associated, these observations suggest that
covering a MLD could be the primary function of the T3S
effector chaperones.
Results
orf155 encodes a protein that has the characteristics
of chaperones of effector proteins
In the three pathogenic Yersinia species, the operon encod-
ing YopO (YpkA) and YopP (YopJ) contains a small open
reading frame (orf) encoding a 142- (Y. pestis KIM) to 155-
(Y. enterocolitica E40) residue acidic protein (Galyov et al,
1994; Iriarte and Cornelis, 1999) (Supplementary Figure S1).
Upstream of residue 133, the three proteins are 98% identi-
cal. Programs searching sequence similarities and fold recog-
nition revealed low but significant similarities between
Orf155 and various T3S class-I chaperones (Supplementary
Figure S1). Based on this, a three-dimensional structure, very
similar to that of class-I chaperones, could be derived
(Supplementary Figure S1 and Supplementary data 1).
orf155 encodes SycO, the chaperone of YopO
The entire orf155 was deleted from the pYV plasmid of
Y. enterocolitica E40(pYV40) giving E40(pML4001) (Dorf155
mutant). Yop secretion was triggered by chelating Ca2þ ions
(Cornelis et al, 1987). Under standard induction conditions
(4 h), all the Yops were detected in the culture supernatant
(not shown). However, when the time allowed for secretion
was reduced, there was less YopO (YpkA) in the culture
supernatant of mutant bacteria than in the culture super-
natant of wild-type (wt) bacteria (Figure 1A). No other Yop,
including YopP, encoded downstream of orf155 and yopO was
affected, indicating that the mutation was non-polar (data not
shown). As known for the other T3S chaperones, SycO itself
was not secreted (data not shown).
We then monitored translocation of YopO into macro-
phages during the infection of a cell culture, using the adenyl-
ate cyclase (Cya) reporter method (Sory and Cornelis, 1994).
We introduced plasmid pCD10, encoding the first 143 amino
acids of YopO fused to Cya, into wt Y. enterocolitica E40 as
well as into the Dorf155 mutant and various control strains
and we infected cultured J774 macrophages. Cells that were
infected by wt bacteria accumulated cAMP. In contrast, cells
infected with the Dorf155 mutant did not produce more cAMP
than cells infected with translocation-deficient bacteria
DHOPEMNB (Figure 1B). Complementation of Dorf155
mutant bacteria with plasmid pML4 restored translocation
of YopO up to the wt level (Figure 1B). These experiments
showed that the product of orf155 is required for transloca-
tion of YopO and hence, given its similarity to Syc chaper-
ones, it was tentatively called SycO.
To ascertain that translocation of YopP was not dependent
on SycO, we monitored apoptosis of macrophages infected
by wt Y. enterocolitica E40(pYV40) and by Dorf155 Y. entero-
colitica E40(pML4001). No difference could be seen between
the two infected cultures (data not shown), confirming that
SycO is not the chaperone of YopP, as shown earlier (Trulzsch
et al, 2003).
SycO binds to residues 20–77 of YopO
To confirm that SycO is the chaperone of YopO, we tested
whether the two proteins interact and how. The sycO-yopO
genes were coexpressed in Escherichia coli BL21 and SycO
was co-purified with YopOhis (data not shown) suggesting
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Figure 1 The Dorf155 mutant is impaired in secretion and translo-
cation of YopO. (A) Plasmid pISO56 encoding YopOflag was intro-
duced into wt E40(pYV40) bacteria and into Dorf155 mutant
bacteria E40(pML4001). Yop secretion was induced by incubating
at 371C in a medium deprived of Ca2þ ions. Samples of the
supernatant were taken at different time points after shift of the
culture from 28 to 371C. YopOflag was detected by immunoblot. Top,
wt; bottom, Dorf155 mutant. The lower background band shows
that an equivalent amount of supernatant has been loaded in each
lane. (B) Translocation of the YopO-Cya reporter into infected J774
macrophages. Plasmid pCD10 encoding YopO143-Cya was intro-
duced into E40(pYV40) wt bacteria, into Dorf155 knockout bacteria
E40(pML4001) and into the translocator-deficient E40(pCNK4008)
(called DHOPEMNB). The low-copy plasmid pML4 encoding sycO
complemented the Dorf155 mutation, whereas the vector alone did
not. Cellular levels of cAMP were assayed after infection.
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that the two proteins form a complex when synthesized
together in E. coli. To ascertain this observation, a sample
of co-purified proteins was loaded on an analytical gel
filtration column. YopO and SycO eluted together around
fraction 9 (Figure 2A), whereas purified SycO loaded alone
eluted around fraction 14 (Figure 2B). To localize the CBD
of YopO, three different YopO-Cya hybrid proteins were
produced in the multi-effector knockout Y. enterocolitica
DHOPEMT together with GST-SycO. YopO143-Cya and YopO77-
Cya co-purified with SycO on glutathione Sepharose, whereas
YopE20-Cya did not (not shown). These experiments led to
the conclusion that the CBD of SycO is localized within the 77
N-terminal residues of YopO. As SycE binds to residues 15–75
of YopE (Woestyn et al, 1996; Birtalan et al, 2002) and SycH
binds to residues 20–70 of YopH (Woestyn et al, 1996), we
made the assumption that SycO could also bind immediately
after the secretion signal of YopO. To test this hypothesis,
we constructed a GST-YopO hybrid, a variant where residues
20–77 of YopO were deleted (GST-YopOD22–77) and a hybrid
containing only residues 20–77 of YopO (GST-YopO20–77).
All three hybrid proteins were expressed in parallel
in Y. enterocolitica E40. SycO was pulled down together
with GST-YopO and with GST-YopO20–77 but not with GST-
YopOD20–77 (Figure 2C). This indicated that residues 20–77
of YopO include the core of the CBD.
We then investigated the stoichiometry of the YopO–SycO
complex and observed that SycO dimerizes and binds YopO
as a dimer (Supplementary data 2), as known for the other
class-I chaperones.
We finally compared the CBD of YopO to that of YopE
in silico and found that they share a similar secondary struc-
ture, meaning that the YopO CBD is likely to wrap around the
dimer of SycO as the YopE CBD wraps around the dimer of
SycE (Supplementary data 3).
Binding of SycO to YopO does not prevent folding
of the whole protein
It has been proposed that class-I chaperones could keep the
effectors in an unfolded secretion competent state (Stebbins
and Galan, 2001). To test this hypothesis for YopO, we
monitored the autophosphorylating activity of the purified
kinase (Galyov et al, 1993), with and without the CBD. As
YopO was poorly soluble without its chaperone but was more
soluble as a GST fusion or without the CBD, we compared the
kinase activity of GST-YopO to that of YopOD20–77 and YopO-
(SycO)2. As a negative control, we engineered an inactive
GST-YopO hybrid with the D267A substitution in the catalytic
site (Juris et al, 2000). As expected, the kinase activity was
dependent on the presence of actin (Juris et al, 2000)
(Figure 3). Importantly, YopOD20–77 was at least as active as
GST-YopO (Figure 3), showing that the CBD is not needed for
the catalytic activity of YopO. In addition, the YopO-(SycO)2
complex turned out to be as active as GST-YopO, showing that
SycO binding does not prevent folding of the whole protein.
Interestingly, SycO itself was phosphorylated. This has no
physiological relevance, as chaperones are not translocated
into host cells (Wattiau et al, 1994), but it confirms the broad
spectrum activity of YopO (Juris et al, 2000).
YopODCBD can be exported by the Ysc T3S system
and translocated into host cells
To further investigate the role of SycO, we removed the CBD
within YopO and first tested the consequences in terms
of secretion triggered by Ca2þ chelation. We compared
secretion of YopOflag and YopOD20–77flag after 3 h of incubation
at 371C in the presence and absence of SycO. As expected, the
absence of SycO had a negative effect on secretion of YopO
but not on secretion of YopOD20–77. Unexpectedly, there was
more YopOD20–77flag than YopOflag in the supernatant and in
the lysate of wt bacteria (Figure 4A). However, it has been
shown in Salmonella that the chaperone prevents the effec-
tors SptP and SopE to be secreted by the flagellum rather than
by the injectisome (Lee and Galan, 2004). To ensure that
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Figure 2 Characterization of the YopO–SycO interaction. (A)
YopOhis and SycO encoded by pML9 were synthesized in E. coli
BL21 and co-purified on Ni2þ Sepharose. The purified complex (L)
was loaded onto a SuperdexTM 200 gel filtration column and the
eluted fractions (4–15) were analyzed by Coomassie-stained
SDS–PAGE. YopOhis and SycO eluted together around fraction 9.
(B) Purified SycO protein (see Supplementary data 4), loaded on the
same column, eluted around fraction 14. (C) Plasmids pML10,
pML11 and pML17 encoding GST-YopO, GST-YopOD20–77 and GST-
YopO20–77, respectively, were introduced into Y. enterocolitica E40
wt producing SycO from the pYV40 plasmid. GST hybrid proteins
were pulled down from crude extracts, analyzed by SDS–PAGE and
the presence of SycO was monitored by immunoblotting. L, lysate;
U, unbound; W, wash; E, eluted.
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YopOD20–77flag was indeed secreted by the injectisome, we
monitored secretion by Y. enterocolitica W227(pSW2276)
mutated in yscN, the gene encoding the ATPase energizing
the T3S pathway. As shown in Figure 4A, the protein was not
secreted, ruling out secretion by the flagellum. These results
show that, in the absence of SycO, YopO is exported better
without its CBD. This suggests that the CBD itself creates the
need for SycO.
As a protein that is secreted is not necessarily delivered
into cells (Figure 1), we removed the CBD from the YopO143-
Cya reporter protein and monitored translocation. Again, the
observations on in vitro secretion and translocation were
somewhat different. YopO143D20–77-Cya was efficiently deliv-
ered into cells by DHOPEMT bacteria (Figure 4B) but not by
wt bacteria (not shown). Thus, for translocation, we can
conclude that the presence of the CBD and the chaperone
facilitates the delivery of the effector but targeting can occur
in their absence.
SycO prevents the intrabacterial aggregation of YopO
mediated by the CBD
In order to understand why the presence of the CBD reduces
the amount of YopO secreted in vitro, we compared the
solubility of YopO and YopOD20–77 in E. coli. In the absence
of SycO, YopOD20–77his was abundant and mostly soluble,
whereas YopOhis was present in very small amounts and
exclusively in the insoluble fraction (Figure 5A). In the
presence of SycO, there was more YopOhis than in the absence
of SycO and most of it was soluble. This suggested that YopO
is less soluble than YopOD20–77 and that SycO helps solubiliz-
ing YopO.
To confirm this observation, we purified YopO and
YopOD20–77 and the YopO-(SycO)2 complex using GST tags
that were cleaved off at the last stage. Again, the yield of
YopO was much lower than the yield of the two others (not
shown). The three preparations as well as SycO alone were
analyzed by size-exclusion chromatography (Figure 5B).
Whereas SycO, YopO-(SycO)2 and YopOD20–77 were eluted as
expected from their size, YopO appeared in the void volume,
indicating that it was aggregated. Thus, the CBD creates the
need for SycO because it drastically reduces the intrabacterial
solubility of YopO.
The SycO-binding domain is a cell membrane targeting
domain
The previous experiments demonstrated that SycO is required
because of the presence of residues 20–77 in YopO and that
these residues are not involved in the catalytic activity. As
YopO is targeted to the membrane of the host cell (Hakansson
et al, 1996; Dukuzumuremyi et al, 2000), we tested whether
the residues 20–77 would not act as an MLD. To investigate
this possibility, the 30 end of different yopO constructs was
fused to the EGFP gene and HEK293T cells were transfected
with the recombinant plasmids. Whereas EGFP was distri-
buted in the cytosol and the nucleus, YopO-EGFP was pre-
ferentially localized at the plasma membrane, as expected.
Furthermore, cells transfected with plasmid pML1, encoding
YopO-EGFP, became rounded (Figure 6), indicating that the
YopO-EGFP hybrid protein had kept an activity in the cell.
A YopOD267A-EGFP catalytic mutant also localized to the
membrane. This showed that the catalytic activity is not
required for membrane localization. In contrast, YopOD20–77-
EGFP did not localize to membranes and cells transfected
with pML2, encoding YopOD20–77-EGFP, did not round up. We
concluded that the CBD was required for the membrane
targeting and that this membrane localization was necessary
for YopO-EGFP activity (Figure 6). To delineate more accu-
rately the MLD, we fused residues 20–80 and 20–90 of YopO
to EGFP and monitored the localization of the hybrid.
Residues 20–90, but not 20–80, were sufficient to target
EGFP to the membrane. There is thus a good correlation
between the CBD (20–77) and the MLD (20–90).
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Figure 3 Binding of SycO to YopO does not prevent the catalytic activity of YopO. GST-YopO, GST-YopOD267A, YopO(SycO)2 and YopOD20–77,
expressed in E. coli BL21 from plasmids pML10, pML12, pML10þpML15 and pML11 respectively, were semipurified (Supplementary data 4),
incubated with [g-32P]ATP in the presence and absence of actin and analyzed by Coomassie-stained SDS–PAGE (A) and autoradiography (B).
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The CBDs of YopE and YopT are also aggregation-prone
MLDs
The experiments described above demonstrate that SycO is
required to mask the aggregation-prone MLD of YopO inside
the bacterium. We wondered whether this hypothesis could
apply to other class-I chaperones.
Like the CBD of YopO, residues 50–77 of YopE create the
need for SycE (Boyd et al, 2000). Even more, residues 54–75
have been shown to represent an MLD for YopE (Krall et al,
2004). As shown in Figure 7A, YopE90-EGFP expressed in
HEK293T cells showed a peri-nuclear localization including
the cis-Golgi. This does not mean that when YopE is injected
by Yersinia, it would be associated to the Golgi, but it
confirms that the CBD confers some membrane targeting
properties to YopE, as shown earlier (Krall et al, 2004). It
is thus likely that the CBD causes intrabacterial insolubility.
We thus tested the intrabacterial solubility of YopE in the
presence and absence of SycE. As shown in Figure 7D, SycE
clearly increased the solubility of YopE. This result is in
perfect agreement with previous data from Birtalan et al
(2002) showing that binding of SycE rescues purified YopE
from aggregation.
As YopT, like YopE, targets Rho GTPases (Zumbihl et al,
1999; Black and Bliska, 2000; Von Pawel-Rammingen et al,
2000; Shao et al, 2002) and also associates with host cell
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Figure 4 YopOD20–77 can be secreted and delivered into host
cells. (A) Plasmid pISO56 encoding YopOflag or pML16 encoding
YopOD20–77flag was introduced into wt Y. enterocolitica E40(pYV40),
DsycO Y. enterocolitica E40(pML4001) and yscN Y. enterocolitica
E40(pSW2276). Yop secretion was triggered by Ca2þ chelation for
3 h and the supernatants were analyzed by Western blotting.
(B) Translocation of the YopO143D20–77-Cya reporter into infected
J774 macrophages. Plasmid pML31 encoding YopO143D20–77-Cya
(DCBD) was introduced into the multi-effector knockout mutant
E40(pIML421) (called DHOPEMT) and into the translocator-defi-
cient E40(pCNK4008) (called DHOPEMNB). Plasmid pCD10
encodes YopO143-Cya (wt). Cellular cAMP levels were assayed
after infection.
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Figure 5 The CBD causes aggregation of YopO. (A) YopOhis,
YopOD20–77his and YopOhisþ SycO were overexpressed in E. coli
BL21 from plasmids pML7, pML8 and pML9, respectively. The
cleared lysates (see Materials and methods) were centrifuged at
100 000 g to separate soluble (Sn) from insoluble (P) proteins and
analyzed by Western blotting. (B) GST-YopO, GST-YopOD20–77 and
GST-YopO(SycO)2 were synthesized in E. coli and purified as
described in Supplementary data 4. After removal of the GST tag,
the proteins were analyzed on a SuperdexTM 200 gel exclusion
chromatography. Purified SycO (see Supplementary data 4) was
analyzed in parallel.
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membranes (Aepfelbacher et al, 2003), we would predict that
the CBD of YopT is also an MLD. The CDB of YopT has been
localized, by limited proteolysis, between residues 52 and
139 (Buttner et al, 2005). In order to test whether this CBD
would also correspond to the MLD, we fused residues 1–124
of YopT to EGFP and expressed the hybrid in HEK293T cells.
YopT124-EGFP presented a punctuated distribution evoking
either lysosomal association or aggregation (Figure 7B and
C). Using LAMP1 as a lysosomal marker, we observed that
YopT124-EGFP did not colocalize with lysosomes, suggesting
that YopT124 was causing the aggregation of EGFP. We then
tested whether the SycT chaperone would not influence the
intrabacterial solubility of YopT. As shown in Figure 7D, this
was indeed the case.
We fused the first 90 amino acids of YopH to EGFP, but
no specific distribution was observed. EGFP was homo-
EGFP
xy xy xz
EGFP+
WGA Texas Red
EGFP+
WGA Texas Red
EGFP
YopO-EGFP
Fluorescence
Axis
CBD
YopO∆20–77-EGFP
YopO20–80-EGFP
YopO20–90-EGFP
YopOD267A-EGFP
Figure 6 The CBD of YopO is an MLD. The different constructs drawn on the right panel were transfected in HEK293Tcells. Cells were grown
for 24 h, stained with Texas Red-conjugated wheat germ agglutinin, fixed and analyzed by confocal microscopy. The constructs were encoded
by pML1 (YopO-EGFP), pML2 (YopOD20–77-EGFP), pML3 (YopOD267A-EGFP), pML26 (YopO20–80-EGFP) and pML27 (YopO20–90-EGFP).
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geneously distributed in the whole cell (data not shown).
In addition, there was no clear difference in the solubility
of YopH in the presence or absence of SycH.
Finally, we analyzed the cellular localization of YopP, for
which no chaperone was described. The hybrid YopP-EGFP
transfected into HEK293T cells appeared uniformly distri-
buted to the cytosol (not shown).
In conclusion, we suggest that SycO, SycE and SycT cover
an aggregation-prone MLD.
Discussion
In Yersinia, the chaperones of effector proteins are SycE
(Wattiau and Cornelis, 1993; Birtalan and Ghosh, 2001),
SycH (Wattiau et al, 1994; Phan et al, 2004) and SycT
(Iriarte and Cornelis, 1998; Buttner et al, 2005; Locher et al,
2005). SycO described in this paper shares all the properties
of these Syc proteins and clearly represents a new member of
this group. However, its phenotype is somewhat more subtle
and this explains why it is discovered more than 10 years
later than the others. At first sight, SycO does not appear to be
required for in vitro secretion of YopO but it is required for
translocation of YopO into cells. If chaperones are necessary
for export of effector molecules that are stored in the cyto-
plasm, but not for export of those synthesized while the
secretion apparatus is active, as demonstrated by Parsot and
co-workers (Page et al, 2002) for Spa15, then our results
indicate that translocation of YopO into cells is essentially
post-translational. In contrast, in vitro secretion of YopO,
induced by Ca2þ chelation, could be also co-translational.
YopThis YopEhis
YopThis YopEhis
+SycT +SycE
P Sn P Sn P Sn P Sn
α-his
YopE90-EGFP
YopT124-EGFP YopT124-EGFP YopT124-EGFP z -plane
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D
Figure 7 Role of the CBD of YopE and YopT. The fusions YopE90-EGFP (A) and YopT124-EGFP (B, C) were expressed in HEK293T cells after
transfection of plasmids pSAM10 and pSAM12, respectively. Cells were grown 24 h, fixed, permeabilized and immunolabelled with a-Giantin
(A) or a-LAMP1 (C). Pictures were acquired by confocal microscopy. (D) YopEhis and YopThis encoded by pML33 and pML34 were expressed in
E. coli BL21 with or without SycE or SycT encoded by plasmids pSAM13 or pSAM15, respectively. The cleared lysates (see Materials and
methods) were centrifuged at 100 000 g to separate soluble (Sn) from insoluble (P) proteins and analyzed by Western blotting.
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Having shown that SycO is a new member of the group of
Yersinia effector chaperones, we tried to address its function,
taking into consideration the different functions already
proposed for the proteins of this group. We observed that
binding of SycO to YopO does not prevent the activity of the
kinase domain of YopO, implying that the catalytic domain
(residues 160–400) and the actin-binding domain (residues
709–729) (Juris et al, 2000) are folded. Thus, SycO does not
maintain YopO in a completely unfolded secretion-compe-
tent state. This observation is in perfect agreement with the
observation of Birtalan et al (2002) that SycE does not
prevent the GAP activity of YopE and with the observation
of Akeda and Galan (2005) that SicP does not prevent the
tyrosine phosphatase activity of SptP, revising an earlier
interpretation of Stebbins and Galan (2001). For SycO, we
thus rule out that its function is to maintain YopO in an
unfolded state, which also implies that the injectisome
can unfold its substrates during export, as was clearly
demonstrated for SptP by Akeda and Galan (2005).
However, we observed that SycO keeps YopO soluble in the
cytosol of Yersinia before export and that it is precisely
the SycO-binding domain that makes YopO insoluble. Thus,
the presence of the CBD creates the need for the chaperone. As
pointed out by Birtalan et al (2002), it is unlikely that chaper-
ones exist simply to mask an aggregation-prone effector region
whose only function is chaperone binding. We thus looked for a
function of this aggregation-prone domain and we found that it
was an MLD. A function of SycO is thus to hide the aggregation-
prone MLD of YopO while YopO is in the bacterium.
Would this new function apply to other class-I chaperones?
Previous data from Krall et al (2004) and data presented here
show that it also applies to YopE. It probably also applies to
YopT because the CBD causes aggregation of transfected
hybrid proteins in the host cell. However, it should still be
demonstrated that this domain targets YopT to the membrane
when YopT is injected rather than transfected. We also tried
to extend the hypothesis to YopH, which targets focal adhe-
sions (Persson et al, 1999) and another membrane-associated
complex (Black et al, 2000). We did not observe any
membrane localization of transfected YopH90-EGFP and any
change in the intrabacterial solubility of YopH with or with-
out SycH. However, for YopH, the situation could be more
complex as the CBD already partially overlaps with the
phospho-tyrosine recognition domain (Montagna et al,
2001). Moreover, different domains of YopH including its
CBD have been shown to interact with the Fyn binding
protein in macrophages (Yuan et al, 2005). Thus, the CBD
of YopH might not be a membrane targeting domain, it is
nevertheless an intracellular targeting domain. In good agree-
ment with our hypothesis about class-I chaperones, YopM
(Benabdillah et al, 2004) and YopP, which do not have a
chaperone, do not localize to membranes. In Yersinia, there is
thus a correlation between the presence of a chaperone and
an activity of the effector at the membrane of the target cell.
Would this new hypothesis about effector chaperones and
MLDs also apply to effectors of other T3S systems? The
hypothesis predicts that the effectors that have a chaperone
would act at the membrane of the host cell. Among the
best-characterized class-I chaperones, we find SicP (Fu and
Galan, 1998) and SigE (Darwin et al, 2001) from Salmonella
enterica, CesT from enteropathogenic E. coli (Elliott et al,
1999) and Spa15 from Shigella (Page et al, 2002). SptP, the
partner of SicP, is a GAP for Rho (Fu and Galan, 1999) and
has been shown to localize at the plasma membrane of
infected cells (Cain et al, 2004); SigD/SopB, the partner of
SigE, is an inositol phosphatase (Norris et al, 1998), which
was shown to be membrane-associated (Marcus et al, 2002;
Cain et al, 2004); Tir, the partner of CesT, is the membrane-
associated intimin receptor (Kenny et al, 1997); and finally,
Spa15 is, among others, the chaperone of IpaA, which con-
tributes to Shigella entry by binding the focal adhesion
protein vinculin (Tran Van Nhieu et al, 2000). Thus, all
these effectors have a chaperone of the SycE family, and are
targeted to the membrane. Furthermore, the Salmonella
effectors SopE, SopE2 and SipA, which all share the InvB
chaperone (Bronstein et al, 2000; Ehrbar et al, 2003), have
also been shown to localize at the membrane of infected cells
(Cain et al, 2004).
Does this new function for class-I chaperones exclude any
targeting function? Certainly not, as the CBD and SycO are
required for efficient delivery of YopO into cells by wt Yersinia
bacteria. This situation is reminiscent of YopE. Indeed, YopE
deprived of its CBD cannot be delivered by wt bacteria but it
can be delivered by mutant bacteria deprived of all the other
effectors (Boyd et al, 2000). Chaperones bound to the effector
thus improve targeting to the secretion apparatus, either by
acting as a three-dimensional secretion signal, as suggested
for SycE (Birtalan et al, 2002), or simply by presenting the
secretion signal. The presence of the chaperone could also
favor the interaction with the ATPase, and so facilitate the
unfolding of the effector (Akeda and Galan, 2005). Our data
do not allow to discriminate between these hypotheses.
We thus suggest that the class-I chaperones have two
functions: (i) cover an aggregation-prone MLD and (ii) facil-
itate export. Which one of these two functions would have
appeared first? As some effectors seem not to have a chaper-
one (YopM and YopP in Yersinia), we would speculate that the
primary function of effector chaperones is to cover an MLD
and that targeting of effector chaperone complexes has been
gradually optimized by evolution. In support of this view,
YopO and YopE deprived of their CBD can be translocated by
multi-effector knockout mutant bacteria. CBDs and chaper-
ones thus evolved to serve two different essential functions,
one inside the bacterium and one inside the host cell.
Materials and methods
Bacterial strains, plasmids and genetic constructions
Y. enterocolitica E40 (Sory and Cornelis, 1994) and W22703
(Cornelis et al, 1986), both from serotype 0:9, were used for T3S
experiments. E. coli BL21 was used for protein expression and E. coli
Top10 was used for plasmid amplification and cloning. Plasmids are
listed in Table I. Oligonucleotides labelled with * in Table I were
used to delete or mutate domains by inverse polymerase chain
reaction, using the Pfu turbo polymerase (Stratagene). Every
construct was sequenced using 3100-Avant genetic analyzer (ABI
Prism). Oligonucleotides are listed in Supplementary Table S1.
Induction of type III secretion by low Ca2þ
This was carried out as described earlier (Agrain et al, 2005).
Standard protein purification and analysis protocols
See Supplementary data 3.
Ultracentrifugation of crude extracts
YopOhis, YopOD20–77his and SycO coexpressed with YopOhis were
produced in E. coli BL21 from the pET22 vector using plasmids
pML7, pML8 and pML9. Bacteria were grown overnight at 371C,
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Table I List of the plasmids used in this work
pYV derivatives
Plasmids Characteristics References
pYVe227 wt pYV plasmid from Y. enterocolitica W227 Cornelis et al (1986)
pYV40 wt pYV plasmid from Y. enterocolitica E40 Sory et al (1995)
pML4001 pYV40: sycO This study
pAB406 pYV40: yopOD65–558 Mills et al (1997)
pSW2276 pYV40: yscND169–177 Woestyn et al (1994)
pIML421(DHOPEMT) pYV40: yopHD1–352, yopOD65–558, yopP23,
yopE21, yopM23, yopT135
Iriarte and Cornelis (1998)
pCNK4008 (DHOPEMNB) pYV40: yopHD1–352, yopOD65–558, yopP23,
yopE21, yopM23, yopN45, yopBD89–217
Neyt and Cornelis (1999)
Clones
Plasmids Characteristics Derivation and oligonucleotides used References
pCD10 pTM100HyopO143-cyaA0(sycE promoter) Unpublished
pCD11 pTM100HyopO77-cyaA0(sycE promoter) Deletion of the MunI/HindIII
fragment in pCD10
Unpublished
pISO56 pBBR1 MCS2HyopOflag(yopE promoter) Flag-tag insertion in pMAF60 *(3688/3710) This study
pMAF60 pBBR1 MCS2HyopO(yopE promoter) Cloning of yopO from pYOB2 3118/3119 This study
pML1 pEGFP(N)HyopO Cloning of yopO 3394/3395 This study
pML2 pEGFP(N)HyopOD20–77 Deletion from pML1 *(3396/3397) This study
pML3 pEGFP(N)HyopOD267A Mutation on pML1 *(3484/3485) This study
pML4 pBBR1 MCS2HsycO Cloning of sycO 3266/3271 This study
pML7 pET22HyopOhis Cloning of yopO 3523/3525 This study
pML8 pET22HyopOD20–77 his Deletion from pML7 *(3396/3397) This study
pML9 pET22HsycO-yopOhis Cloning of sycO-yopO 3524/3525 This study
pML10 pGEX-6p-1HyopO Cloning of yopO 3698/3699 This study
pML11 pGEX-6p-1HyopOD20–77 Deletion from pML10 *(3396/3397) This study
pML12 pGEX-6p-1HyopOD267A Mutation on pML10 *(3484/3485) This study
pML13 pGEX-6p-1HyopO200 Cloning of yopO200 3523/3908 This study
pML14 pBADHsycO Cloning of sycO 3268/3250 This study
pML15 pCDFHsycO Cloning of sycO 3268/3271 This study
pML16 pBBR1 MCS2HyopOD20–77 flag (yopE promoter) Deletion from pISO56*(3396/3397) This study
pML17 pGEX-6p-1HyopO20–77 Cloning of yopO20–77 4015/4028 This study
pML18 pKSH250/sycO/+250 Cloning of 250/sycO/+250 3266/3267 This study
pML19 pKSH250/DsycO/+250 Deletion of sycO from pML18 *(3272/3273) This study
pML26 pEGFP(N)HyopO20–80 Cloning of yopO20–80 4134/4079 This study
pML27 pEGFP(N)HyopO20–90 Cloning of yopO20–90 4134/4080 This study
pML31 pBBR1 MCS2HyopO143D20–77-cyaA0(sycE promoter) Deletion from pCD10*(3396/3397) This study
pML33 pET22HyopEhis Cloning of yopE 4306/4309 This study
pML34 pET22HyopThis Cloning of yopT 4307/4310 This study
pMSLE20 pTM100HyopE20-cyaA0 Sory et al
(1995)
pSAM10 pEGFP(N)HyopE1–90 Cloning of yopE1–90 4293/4294 This study
pSAM12 pEGFP(N)HyopT1–124 Cloning of yopT1–124 4297/4298 This study
pSAM13 pCDFHsycE Cloning of sycE 4301/4302 This study
pSAM15 pCDFHsycT Cloning of sycT 4299/4300 This study
pYOB2 pCNR26HyopO(yopE promoter) Cloning of yopO 471/473 This study
Cloning vectors
Plasmids Characteristics References
pBADmyc-his A pBAD promoter, high copy Invitrogen
pBBR1-MCS2 Medium–low copy Kovach et al (1995)
pBluescript II KS (+) Stratagene
pCDF-Duet T7 promoter Novagen
pCNR26 yopE promoter Sarker et al (1998)
pEGFP-N1 CMV IE promoter BD Biosciences Clontech
pET22 T7 promoter, lac operator, high copy Novagen
pGEX-6p-1 pTac promoter Amersham
pTM100 pACYC184-oriT Michiels and Cornelis (1991)
Suicide vectors, mutator
Plasmids Characteristics References
pKNG101 ori R6K, mob RK2, strAB, sacBR Kaniga et al (1991)
pML20 pKNG101H250/DsycO/+250 This study
Oligonucleotides labelled with * were used to delete or mutate domains by inverse polymerase chain reaction using Pfu turbo polymerase
(Stratagene).
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diluted to an OD600 of 0.1 in LB with ampicillin 100mg ml
1 and
incubated at 371C until they reached an OD600 of 0.6. Then, the
expression of the proteins was induced by adding 0.125 mM IPTG
and the cultures were incubated at room temperature (RT) with
shaking for 3 h. Cells were harvested by centrifugation, resus-
pended in PBS containing Triton X-100 0.1% (v/v), protease
inhibitors (Complete mini, Roche) and lysed by using a French
press. The lysate was spun for 30 min at 6000 g to eliminate
unbroken cells and debris. The supernatant was centrifuged for 1 h
30 min at 100 000 g to separate soluble compounds (supernatant)
from insoluble ones (pellet).
Kinase assay
Proteins were purified as described in Supplementary data 4. YopO
and YopOD267A were eluted together with GST in order to improve
their solubility. The purified YopO-(SycO)2 complex used for the
kinase assay was previously run on gel filtration in order to use only
proteins associated in a complex. Kinase assays were performed
using 5mg of purified proteins in the kinase reaction buffer: PBS,
20 mM MgCl2, 1 mM DTT, 0.5 mM ATP and 2mCi [g-
32P]ATP,70.1mg
of purified G-actin (Pierce). The reaction was incubated at 301C for
30 min and stopped by addition of SDS–PAGE loading buffer. The
kinase reactions were loaded on SDS–PAGE gel. The autoradio-
graphy was obtained on Phosphor Screen (Molecular Dynamics).
Adenylate cyclase reporter translocation assay
J774 macrophages were grown in RPMI 1640 medium (Gibco BRL),
supplemented with 2 mM L-glutamine (Invitrogen), 1 mM sodium
pyruvate (Invitrogen), 0.0004% (v/v) b-mercaptoethanol (Sigma) and
10% (v/v) fetal bovine serum (Invitrogen). Adenylate cyclase reporter
translocation assays were carried out as described earlier (Sory and
Cornelis, 1994). All experiments were performed in triplicate.
Transfection and fluorescence microscopy
HEK293T cells were grown in Dulbecco’s modified Eagle’s medium
(Gibco BRL), supplemented with 10% (v/v) fetal bovine serum
(Invitrogen) and 1 mM sodium pyruvate (Invitrogen). Coverslips
(Huber & Co) were coated with poly-lysine (BD Diagnostic System),
and 104 cells well1 were seeded in 500 ml of media. The next day,
cells were transfected following the calcium phosphate procedure.
Cells were grown for 24 h, stained with 10 mg ml1 wheat germ
agglutinin Texas Reds-X conjugate (Molecular Probes) for 7 min at
RTand fixed for 20 min in 3% paraformaldehyde in PBS. For Giantin
and LAMP1 staining, cells were permeabilized with 0.1% saponin
in PBS containing 3% BSA, incubated during 40 min with a-Giantin
(G1/133) or a-LAMP1 (G1/139) (Axxora), washed and incubated
for 30 min with a Texas Reds-coupled secondary antibody
(Molecular Probes). Slides were examined with a Leica TCS SP
confocal microscope. Pictures were processed with the Leica
confocal software version 2.5.
Supplementary data
Supplementary data are available at The EMBO Journal Online.
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In silico study of SycO: (Supplementary material 1)
orf155 encodes a protein which presents the characteristics of class I
chaperones:
The operon encoding YopO and YopP (Fig S1A) contains orf155. A similar orf is found in the
three pathogenic Yersinia species (Fig S1B). Although the size varies from 142 to 155 residues,
the proteins are 98 % identical within their 133 first residues. Similarities between Orf155 and
other effector chaperones were investigated using PSI-BLAST (Altschul et al., 1997) and fold
recognition algorithms 3D-PSSM (Kelley et al., 2000) and FUGUE (Shi et al., 2001). These
studies revealed low but significant similarities of the conserved protein sequence with various
T3S chaperones, including those of CesT, the chaperone of the enteropathogenic E. coli
effector Tir (Thomas et al., 2005) and of SicP, the chaperone of Salmonella effector SptP (Fu
and Galan, 1998). Hydrophobic cluster analysis (Callebaut et al., 1997) allowed to point out two
dimensional similarities refining the proposed alignment (Fig S1C and S1D). The model of the
three-dimensional structure of the orf155 gene product, build with the program MODELLER
(Sali et al., 1995) on the basis of this alignment using the SicP structure as template, showed an
organization of the chaperone core structure very similar to those of several T3S chaperones
(Fig S1E, 0.57 Å root mean square deviation (Cα atoms)). The model was constructed in a
dimeric form, based on the dimer observed in the crystal structure of the SicP/SptP complex. As
in SicP, several hydrophobic residues form hydrophobic patches at the surface of the dimer,
which could be involved in the interaction with the effector (data not shown). These
observations suggested that orf155 encodes the chaperone of an effector.
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Fig S1: In silico study of orf155.
A. The operon encoding YopO and YopP starts with orf155 in all three Yersinia pathogenic
Yersinia species. B. The orf155 is highly conserved in the three species (entero = Y.
enterocolitica; pseudotb = Y. pseudotuberculosis; pestis = Y. pestis), which is not the case
for orf91a. C. Alignment of the SycO sequence with that of SicP, the three-dimensional
structure of which is known (Stebbins and Galan, 2001). This alignment was deduced from
PSI-BLAST and fold recognition methods and was refined using "Hydrophobic Cluster
Analysis" (HCA, see below). D. Comparison of the 2D HCA plot of the SycO sequence with
those of CesT and SicP, highlighting the conservation of a common core of hydrophobic
residues. The sequences are shown on duplicated alpha-helical nets, in which hydrophobic
residues (VILFMYW) are contoured. These form clusters, which mainly correspond to
regular secondary structures. Correspondences to the observed secondary structures (CesT
and SicP) are indicated above the plots. Cluster similarities, indicating the conservation of a
common hydrophobic core, are shown in color. Note that the C-terminal sequences,
following the conserved common cores, are variable from one sequence to another one (or
is even absent in SicP). E. Model of the threedimensional structure of the SycO dimer,
based on the dimer structure of SicP (Stebbins and Galan, 2001). Colors of regular
secondary structures are as in panel D.
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Stoichiometry analysis of the YopO-SycO complex by
crosslinking: (Supplementary material 2)
SycO is a dimer and binds as a dimer (Fig. S2 ):
Since the CBD is localized in the N-terminal domain of the protein, a truncated version of YopO
was used to determine the stoechiometry of the complex. A GST-YopO200 fusion protein was
co-expressed with SycO in E. coli BL21 and the complex was adsorbed on glutathione
sepharose, eluted by proteolytic cleavage of the GST moiety, cross-linked with glutaraldehyde
and analyzed by SDS-PAGE and immuno-blotting. Cross-linking led to a shift in the apparent
molecular mass of SycO from 17 kDa to 55 kDa suggesting that YopO200 was associated with
two molecules of SycO (Fig S2A). YopO200 (21 kDa) was not detected any more after cross-
linking, suggesting that all the proteins reacted in the cross-linking reaction. However, the cross-
linked product was not clearly detectable with the α-YopO antibodies, which could result from
the fact that most of the YopO epitopes that remain in this truncated protein are hidden by the
chaperones. In agreement with this hypothesis, when YopOhis full-length was cross-linked with
SycO, a high molecular mass complex was detected by the α-YopO antibodies (Fig S2B). The
SycO-YopO200 complex was also analyzed by size exclusion chromatography and its apparent
molecular weight was evaluated around 60-70 kDa (data not shown), suggesting that the
stoichiometry of the complex is indeed two SycO chaperones for one YopO. Finally, we
analyzed the state of SycO in the absence of YopO. Purified native SycO was crosslinked with
glutaraldehyde and its apparent molecular mass appeared to be around 35 kDa, indicating that
unbound SycO exists as a dimer (Fig S2C).
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Figure S2 : Stoichiometry of the YopO-SycO complex by crosslinking.
A. The complex between YopO200 and SycO, obtained after cleavage of GST-YopO200-(SycO)2 was
treated with glutaraldehyde 0.25 % (v/v) for 5 min at room temperature. The reaction was stopped on ice
by the addition of 100 mM Tris-HCl pH 8.0. The products were analyzed by Coomassie-stained SDS-
PAGE and western blotting. The arrow points to the ca 55-kDa cross-linked product. X = lanes with the
cross-linker; - = control lanes.
B. Same experiment as in A with the YopOhis-(SycO)2 complex preparation loaded in lane L of panel A.
C. Purified SycO protein cross-linked as in A and B.
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In silico study of YopO and YopE chaperone binding domain:
(Supplementary online material 3)
The HCA plots of the YopO and YopE CBDs are shown (see legend of Fig S1 for explanation),
highlighting similarities within hydrophobic clusters (shaded grey). Sequence identities are
reported in white on a black background. These similarities suggest a common secondary
structure organization between the two protein domains. Secondary structures, as observed in
the YopE/SycE complex (PDB 1L2W, (Birtalan et al., 2002)), are reported below the YopE
sequence. A ribbon representation of the YopE/SycE complex 3D structure is shown at the
bottom, with the YopE CBD shown in black.
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Protein purification and analysis: (Supplementary online
material 4)
In order to perform different in vitro studies, we prepared several protein purifications. YopOhis
co-expressed with SycO was purified to study the stoichiometry of the complex by crosslinking
and size exclusion chromatography. GST fusions with different versions of YopO were used to
investigate the stoichiometry, and to test the kinase activity of YopO with or without its
chaperone SycO. Native SycO was also purified for antibody production, stoichiometry analysis
and for eventual future crystallization. Purified YopO and SycO were also used to study their
solubility in vitro.
Purification of the YopOhis-(SycO)2 complex (Fig. 16):
YopOhis and SycO were co-produced in E. coli BL21 from the pET22-derived plasmid pML9.
Bacteria were grown overnight at 37 °C, diluted to an OD600 of 0.1 in LB with ampicillin 100 _g
ml-1 and incubated at 37 ºC until they reached an OD600 of 0.6. Then, the expression of the
proteins was induced by adding 0.125 mM IPTG and the cultures were incubated at room
temperature (RT) with shaking for 3 hours. Cells were harvested by centrifugation, resupended
in PBS containing Triton X100 0.1 % (v/v), proteases inhibitors (Complete mini, Roche) and
lysed using a French press. The lysate was spun for 30 min at 6000 g to eliminate unbroken
cells and debris. YopOhis was purified on Ni
2+- Sepharose (Amersham). After several washing
steps with 100 mM imidazole, YopOhis and SycO were eluted with 300 mM imidazole.
Purification of the GST-YopO fusions (Fig. 17):
GST-YopO (pML10), GST-YopOΔ20-77 (pML11) and GST-YopOD267A (pML12) were produced in
E. coli Top10. GST-YopO (pML10) and SycO (pML15) were co-expressed in E. coli BL21.
Bacteria were cultivated in 100 ml LB medium at 37 °C up to an OD600 of 0.6. Expression of the
fusion proteins was induced by addition of 0.125 mM IPTG. Cultures were then grown for 3
hours at room temperature (RT). Bacterial pellets were resuspended in Phosphate Buffered
Saline (PBS) containing Triton X100 0.1 % (v/v), proteases inhibitors (Complete mini, Roche)
and lysed by sonication. Unbroken cells and debris were removed by centrifugation (30 min,
6000g). The supernatant was incubated with Glutathione Sepharose 4B (Amersham) for 2
hours at 4 °C. The matrix was pelleted by centrifugation 500 g for 2 min. The supernatant was
discarded and the matrix was washed 4 times with ice-cold PBS.
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Figure 17: GST fusions purification.
GST-YopO, GST-YopOΔ20-77, GST-
YopOD267A were produced in E.coli
Top10 from pML10, 11, 12
respectively. GST-YopO and SycO
were co-produced in E.coli BL21 from
pML10 and 15. Samples of bacteria
were analysed by Coomassie stained
SDS PAGE (Fig. 17A), before
induction (-) and after three hours of
IPTG induction (+). The expression of
sycO was checked by Western blot
analysis. After standard purification
procedure (cf. Supplementary materi-
al) and Precission protease elution,
purified fractions were loaded on SDS
PAGE and stained with Coomassie
(Fig. 17B). GST-YopO200 was co-
produced with SycO and purified
following the standard procedure (Fig.
17C) (cf. Supplementary material).
Figure 16 : YopOhis – SycO complex purification.
YopOhis and sycO were co-expressed in E.coli BL21 from pML9. Samples of bacteria were analysed by
Coomassie stained SDS PAGE (Fig. 16A), before induction (non induced) and after three hours of
induction (+IPTG). After lysis cells debris were eliminated by centrifugation and the supernatant was
loaded on Nickel Sepharose (His-TrapTM). After washing with loading buffer (Wash), two step gradients of
imidazole were applied. YopOhis and SycO co-eluted at a concentration of 300 mM imidazole (Fig. 16B).
The three fractions were pooled for further experiments.
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YopO, YopOΔ20-77, YopOD267A, and YopO bound to SycO were eluted using Prescission Protease
from Amersham (3 h at 4 °C). Matrix was sedimented at 500 g for 2 min, and discarded. The
supernatant containing the proteins was checked by SDS PAGE. A major difference in the
recovered protein was observed comparing YopO and YopOD267A to the others. According to the
previous observations made about the solubility of YopO due to the chaperone binding domain.
Repeating the same experience, we hypothesized that YopO could aggregate on the matrix. We
then decided to elute YopO and YopOD267A, with the GST moiety to improve a bit the solubility.
After the washing steps, GST-YopO and GST-YopOD267A were eluted by addition of PBS with 10
mM reduced glutathione to the matrix and incubated for 30 min at 4 °C.
YopO200 was produced from pML13 with SycO (pML15) in E. coli BL21. Expression and
purification was made following the procedure described above for YopOΔ20-77 and YopO co-
expressed with SycO.
Purification of SycO (Fig. 18) :
Expression of SycO. E. coli Top10 containing pML14 (pBAD::sycO) were grown in 25 l LB
medium at 37 °C. Expression of sycO was induced at an OD600 of 0.6 by the addition of 0.2 %
(w/v) arabinose and the culture was grown for three additional hours. The expression was
checked on Comassie (Fig. 18A).
On the 90 grams of bacteria harvested, 30 grams were lysed using a French press in presence
of proteases inhibitors (Complete mini, Roche). Unbroken cells and debris were pelleted by
centrifugation during 30 min at 6000 g.
Ammonium sulfate precipitation. The lysate was sequentially precipitated with ammonium
sulfate. Two cut offs were performed: 30 % and 45 % (w/v) ammonium sulfate. SycO,
precipitated with 30% ammonium sulfate, was dialyzed and further purified by successive
chromatography. All purifications and dialyses were done in Hepes buffer : Hepes 50 mM, NaCl
50 mM, DTT 1 mM buffer containing proteases inhibitors (Complete mini, Roche).
DEAE-Sepharose (Amersham): (Fig. 18B). The dialyzed sample from ammonium sulfate
precipitation was loaded on DEAE Sepharose. The separation was made applying a gradient of
NaCl from 50 mM to 500 mM. Fractions 32 to 38 were pooled and dialyzed overnight in Hepes
buffer.
Q-Sepharose (Amersham): (Fig. 18C). The dialyzed 32-38 pool was loaded on Q-sepharose.
The separation was made applying a gradient of NaCl from 50 mM to 500 mM. Fractions 52 to
63 were collected in a first pool (Pool 1) and dialyzed. Fractions 64 to 84 (Pool 2) were also
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collected and kept frozen at –80 °C in 10 % Glycerol after dialysis in Hepes buffer. The Pool 1
was concentrated from 45 ml to 20 ml with a stirred cell Amicon 8050.
Mono Q (Amersham): (Fig. 18D). One ml of the Q-Sepharose pool 1 was loaded on Mono-Q.
The separation was made applying a gradient of NaCl from 50 mM to 500 mM. Except the
fraction 19, some high molecular weight contaminants were present in almost all the other
fractions of interest (20 to 27). Another final step was then tested, by size exclusion
chromatography.
Sephacryl S-300 (Amersham): (Fig. 18E). One ml of the Q-Sepharose pool 1 was loaded on
Sephacryl S-300 and eluted with Hepes buffer. The final concentration of purified SycO was 1
mg/ml in 15 ml without concentration.
Figure 18 : SycO purification.
SycO was expressed from pML14
in E.co l i Top10. Samples of
bacteria were analysed by
Coomassie stained SDS PAGE
(Fig. 18A), before induction (ni),
three hours after arabinose
induction (i). After induction a
sample of bacteria was lysed.
Soluble (s) and insoluble (ns)
fractions were separated and
analysed. After ammonium sulfate
precipitation and dialysis, proteins
were loaded on DEAE sepharose
and eluted applying a NaCl
gradient (Fig. 18B). The protein
separation and the content of the
fractions was analysed by
Coomassie stained SDS PAGE.
Most of the SycO protein was
present in fractions 32 to 38.
These fractions were pooled,
dialysed and  loaded on Q
sepharose (Fig. 18C). Eluted
fractions were loaded on SDS
gels and stained by Coomassie.
Two pools were collected, from
fraction 51 to 63 (Pool 1) and from
fraction 64 to 84 (Pool 2). Further
purification steps were made of
sample issued from the Pool 1
after dialysis. A sample was
separated by MonoQ (Fig. 18D)
and another by size exclusion
chromatography (Fig. 18E).
V. Supplementary Material
51
Antibody production:
A sample containing 1.5 mg of purified SycO was sent to the CER of Marloi (Belgium) for
antibody production.
VI. Unpublished Results
52
VI. Unpublished Results
VI. Unpublished Results
53
Stoichiometry analysis of the YopO - SycO complex by
Analytical size exclusion chromatography (Fig. 19) :
The crosslinking data about the complexes stoichiometry published in Letzelter et al. were
supported by size exclusion chromatography analyses. Purified proteins were loaded on
Superdex™ 200 PC 3.2/30 gel filtration column (Amersham). All runs were performed in PBS
containing 1 mM DTT. The peaks corresponding to the retention volumes have been integrated
and compared to the calibration run of the column (Fig. 19).
YopO alone eluted in the void volume as aggregates. All other proteins : YopOhis-SycO
complex, YopOΔ20-77, YopO200-SycO complex and SycO were eluted according to their apparent
molecular mass. YopO has a molecular mass of 81.3 kDa, YopOΔ20-77 of 74.8 kDa, YopO200 of
22.1 kDa, and  SycO of 17.2 kDa. SycO alone in solution eluted with an apparent molecular
mass of 31 kDa. The apparent molecular mass of complexes YopO-SycO (120 kDa) or
YopO200-SycO (62 kDa) fitted with a 1:2 stoichiometry, confirming crosslinking observations.
The stoichiometry of the YopO-SycO complex is typical from the Class I chaperone effector
complexes.
Figure 19A : Stoichiometry analysis by Size exclusion chromatography.
The apparent molecular mass of purified proteins and complexes was determined by gel filtration to
analyse their stoichiometry. Purified YopO, YopOΔ20-77, SycO,  YopOhis or YopO200 in complex with SycO
were loaded on Superdex 200 PC 3.2/30. Elution profiles are presented in Figure 19A, analysis of the data
are presented in Figure 19B (next page).
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In vitro binding and solubilization of YopO by SycO (Fig. 20) :
YopO is aggregating through its chaperone binding domain and this event is prevented by the
presence of the chaperone. We checked if the binding of the chaperone could occur in vitro
using purified proteins. Purified YopO (~ 5 µg) was mixed and incubated with purified SycO
added in large excess (~ 20 µg). After overnight incubation at 4 °C (as described in (Birtalan et
al., 2002)) the protein mixture was loaded on Superdex™ 200 PC 3.2/30 and analyzed.
YopO alone eluted as previously in the void volume around fraction 3-4 (Fig. 20A). When YopO
was incubated with SycO part of it still eluted in the void volume. Nevertheless, we could
observe some YopO eluting until fractions 9-10 (Fig. 20B). These fractions corresponded to the
volume at which the YopO-SycO2 complex usually eluted. Thus, part of the aggregated YopO
could be solubilized in vitro by the binding of SycO. However, the efficiency is limited and was
Figure 19B : Stoichiometry analysis by Size exclusion chromatography.
Elution volumes were compared the elution volume of the molecular standards and the
apparent molecular mass of the proteins and the complexes was determined.
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weakly visible on the elution profile. In order to bind in an efficient way, chaperones may rather
associate in a co-translational way with their partner -before they undergo aggregation- than
with post-synthesized substrate.
Figure 20 : In vitro solubilization of YopO by SycO:
Purified YopO was loaded on a Superdex 200 PC 3.2/30 and eluted by size exclusion
chromatography. YopO alone eluted in fractions 3 and 4 corresponding to the void volume (Fig. 20A).
YopO is aggregated. When previously incubated with SycO, part of YopO was still aggregated and
eluted around fraction 4, but some tailing appeared and some YopO eluted in the fraction 9 – 10 (Fig.
20B), where the YopOhis-SycO complex has been shown to elute. Part of the injected YopO was
solubilized by the chaperone.
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Deletion of sycO by allelic exchange : (Fig. 21)
The region containing sycO was amplified by PCR from 250 bp upstream, until 250 bp
downstream the gene using primers 3266/3267. The PCR product was digested by SalI and
XbaI, loaded and purified on agarose gel and ligated into pBluescript KS vector giving pML18.
The whole sycO gene was deleted from the start until the stop codon by inverted PCR on
pML18 using primers 3272/3273. The PCR product was incubated with 1 µl DpnI for 3 hours at
37 °C to digest the template pML18. After purification on agarose gel, the product was ligated
overnight at 16°C and transformed into E.coli Top10, producing the plasmid pML19.
The insert containing the mutated region of sycO was extracted from pML19 by SalI/XbaI
digestion and ligated into the plasmid pKNG101 giving pML20. This mutator plasmid was
transferred from an E.coli SM10 donor strain to Yersinia entrerocolitica MRS40 by conjugation.
After propagation, sycO mutants were screened by colony PCR using primers specific for the
WT 3251/3267 and for the mutant 3266/3267 alleles (Fig. 21D).
Figure 21 : Construction of the sycO mutant by allelic exchange.
The sycO gene was amplified from 250 bp upstream until 250 bp downstream and inserted in the
pBluescript KS giving pML18. PCR amplification of the whole sycO gene from the pML18 is shown in (A)
on the wt level. The sycO gene was deleted from the start to the stop codon by inverted PCR. Only the
flanking regions of sycO are left in the plasmid pML19, (A) on the mutant level. This fragment was
subcloned in the suicide vector pKNG101 resulting in pML20, checked in (B). After conjugation, the first
recombination event was detected by colony PCR (C). Just the lower band of the mutant appears. After
propagation, the second recombination event can lead to the mutant or revert back to the wild type. (D)
The colonies were checked by PCR using oligonucleotides specific for the wild type (wt) or the sycO
mutant (mutant).
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Analysis of the sycO mutant phenotype by in vitro secretion
(Fig. 22) :
We tested the requirement of SycO for the secretion of effectors in vitro in calcium deprived
medium. We compared the patterns of of proteins secreted by different Yersinia enterocolitica
strains: WT MRS40, sycO, sycO complemented with a low copy plasmid containing the sycO
gene with its own promoter (pML4), and a yopO mutant. The precipitated supernatants were
separated by SDS-PAGE. The gels were either stained with Coomassie blue, (Figure 22A) or
analysed by western-blot using α- YopO, α- YopO or α- SycO antibodies (Figure 22B).
The secretion of YopO was reduced in the absence of SycO. When SycO was brought in trans
via pML4, the secretion of YopO increased compared to the sycO strain. Apparently, SycO is
required for an efficient secretion of YopO. On the western-blot, the band corresponding to
SycO in this lane migrated higher. Several versions of SycO exist with variations in the C-
terminal sequences. Here we cloned a version from the virulence plasmid pYVe22703 with an
additional TQS repeat at the end of the protein compared to the MRS40 version. This feature
may confer different migration properties to SycO.
The yopO and yopP genes are encoded downstream sycO. The secretion of YopP was not
modified by the absence of SycO demonstrating that the sycO mutation is not polar and doesn’t
affect YopP (Fig. 2B). Except for YopO, the secretion pattern was the same in all strains (Fig.
22A). None of the other Yops was affected by the lack of SycO. To confirm this observation, we
checked the secretion of the other Yops by western blot using Cya fusions under the yopE
promoter (Figure 22). Again, except for YopO, the secretion of no other Yop was disturbed in
the sycO mutant bacteria.
The use of the in vitro secretion assay to determine the sycO phenotype, as well as the mild
effect of sycO deletion on the secretion pattern prevented the discovery of SycO as the
chaperone of YopO for almost 10 years. This observation brings to consider the limits of in vitro
secretion assays.
Secretion of Yop -Cya hybrid proteins (Fig. 23) :
The N-terminal part of the Yop effectors was fused to the calmodulin dependent adenylate
cyclase (Cya) from Bordetella pertrussis, used as a reporter protein. All fusions were inserted
downstream the yopE promoter. The different strains were incubated in condition inducing in
vitro secretion as described above. The deletion of sycO had an effect only on the
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Figure 22 : Phenotype of the sycO mutant checked by in vitro secretion.
The secretion patterns of different Yersinia enterocolitica strains: WT MRS40, sycO, sycO complemented
with a low copy plasmid containing the sycO gene upon his own promoter (pML4), and a yopO mutant
were compared. Bacteria were incubated in secretive conditions for 3 hours. Supernatant were
precipitated and analysed by Coomassie stained SDS PAGE, (Fig. 22A) or by westernblot using α-YopO,
α-YopP or α-SycO antibodies (Fig. 22B). Comparing the secretion patterns of the WT and sycO strain, we
see that the secretion of YopO is decreased in the absence of SycO. SycO brought in trans via pML4
could improve the secretion of YopO in the sycO mutant. SycO expressed from pML4 migrates higher.
Several versions of sycO exist with different C-term sequences. Here a version from the pYVe22703 with
an additional TQS repeat at the end of the protein was cloned, conferring different migration properties.
Yops other than YopO are not affected by the deletion of sycO (Fig. 22A). YopO and YopP are encoded
downstream sycO. The secretion of YopP is not modified in the sycO mutant. The sycO mutation is not
polar and doesn’t affect YopP.
VI. Unpublished Results
59
secretion of YopO143-CYA (reduced), not on the other Yops hybrids (Fig. 23). Since yopO143-cya
is controlled by the yopE promoter, sycO plays a role in the secretion process, not at the
transcriptional level. The decrease of YopO secretion in the sycO mutant bacteria cannot be
due to a polar effect, as yopO143-cya is encoded on a plasmid. The deletion of sycO has no
impact on the secretion of YopP99 -Cya. Although sycO and yopP are encoded in the same
operon, SycO is probably not a chaperone for YopP.
        
Figure 23 : In vitro secretion of Yop-Cya fusions by Yersinia MRS40 wild-type and sycO:
YopO143-Cya, YopH99-Cya, YopP99-Cya, YopE130-Cya, YopM100-Cya and YopT124-Cya were expressed in
Yersinia MRS40 wild-type and sycO from pCD10, pMSLH99, pMSK3, pMSL28, pAB6 and pAB29
respectively. Bacteria were incubated in secretive conditions for 3 hours. Supernatants were precipitated
and analysed by SDS PAGE and by western-blot using α-SycO, α-Cya, α-GroEL and α-YopE antibodies.
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Stability of YopOflag and YopO20-77 flag in Yersinia MRS40 and
sycO (Fig. 24) :
We investigated if SycO could stabilize YopO in the bacterial cell. We expressed YopOflag from
pISO56 and YopOΔ20-77flag from pML16 in the Yersinia MRS40 wild type or in the sycO mutant.
Bacteria were grown in BHI Ca2+ (5 mM) for 2 hours at 28 °C. The presence of Ca2+ prevents
the release of the Yops into the supernatant. The cultures were shifted to 37 °C for 2 hours.
Chloramphenicol (20 µg/ml final) was added to the test cultures in order to stop protein
synthesis and samples were taken at different time points. The bacterial pellets were loaded on
SDS gels and analysed by western blot.
YopOflag was still present in the cell after 60 minutes in the wt, but not in the sycO mutant (Fig.
24A). Already after 5 minutes we could observe a strong difference comparing the YopOflag level
in the two strains. Apparently YopO was more stable in the presence of SycO. When repeated,
this experiment showed less stability difference between the wild-type and the sycO mutant.
This invites to handle this preliminary result with care. Interestingly, the stability of YopOΔ20-77 flag
was not affected by the absence of SycO (Fig. 24B).
         
Figure 24 : Stability of YopOflag and YopOΔ20-77 flag in Yersinia MRS40 and sycO :
YopOflag (A) and yopOΔ20-77 flag (B) were expressed in Yersinia MRS40 wild-type and sycO from pISO56
and pML16  respectively. Strains were incubated in condition inducing the T3S system, but not secretion
(with 5mM Ca2+). Protein synthesis was stopped in the test cultures by addition of chloramphenicol.
Sample were taken at different time points.
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Cellular localization of YopP-EGFP and YopN-EGFP (Fig. 25) :
Yops effectors with a chaperone of the Class I contain a CBD that is involved in sub-cellular
localization once the effector is delivered in the eukaryotic cell (Letzelter et al., 2006). This
hypothesis valid for YopO, YopE and YopT was also tested for YopP and YopN. As described
previously, yopP and yopN genes fused to egfp were transfected into eukaryotic cells. Then the
distribution of EGFP was monitored by fluorescence microscopy.
The transfected YopP in fusion with EGFP was distributed homogeneously in the cell (Fig. 25).
According to our hypothesis, YopP which has no described chaperone and thus no CBD,
revealed no specific localization properties. Probably YopP has no chaperone at all, or at least
no chaperone of the Class I. The orphan ORFs from the virulence plasmid (pYV) are not
conserved in the three pathogenic Yersinia species. In addition, the putative products of these
ORFs do not present the expected profile of a chaperone.
YopN, does apparently contradict the emitted hypothesis. The transfected YopN fused to EGFP
did not exhibit any particular localization in the cell (Fig. 25). But YopN is somehow peculiar in
the Yop family and its case is described further in the general discussion of this thesis.
These analyses made by fluorescence microscopy are only preliminary studies and do not
constitute a demonstration. They have to be completed by biochemical analyses like cell
fractionation, solubility tests… in order to draw final conclusion.
YopT124 -EGFP kinetic of expression after transfection (Fig. 26) :
After transfection, YopT124 –EGFP expressed in HEK293T cells displayed a punctuated
distribution. According to the poor solubility of YopT, this distribution was likely the consequence
of the aggregation of the EGFP hybrid protein. We tried to monitor the distribution of YopT124 -
EGFP earlier after transfection. The aim was to observe if YopT124 -EGFP could localize before
it aggregates. We made a time course experiment, monitoring EGFP distribution 6 hours, 12
hours and 24 hours after transfection.
After 6 hours, no particular localization could be monitored and some aggregation already
appeared in most of the cells. Aggregation increased at the next time points without any other
localization pattern.
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Figure 25 : Transfection of YopP-EGFP and YopN-EGFP.
YopP-egfp and yopN-egfp were expressed for 24 hours after transfection of HEK293T cells. Cells
were stained with Texas-Red conjugated wheat germ agglutinin (membrane straining), fixed and
analysed by fluorescence microscopy.
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Figure 26 : Transfection of YopT124 –EGFP, kinetic of expression :
YopT124-egfp was expressed from pSAM12 after transfection of HEK293T cells. Cells were grown for 6,
12, or 24 hours after transfection and fixed. Pictures were acquired by confocal microscopy.
VI. Unpublished Results
64
Intrabacterial solubility of YopH in the presence or in the
absence of SycH (Fig. 27) :
The intrabacterial solubility of YopH was assayed as for other YopO, T and E effectors
(described in Letzelter et al. 2006). YopOhis, YopThis and YopEhis were soluble in the presence of
SycO, SycT and SycE respectively. In the absence of their chaperone, they were poorly soluble.
On the opposite YopH was as soluble in the presence or in the absence of SycH.
Figure 27 : Intrabacterial solubility of YopH in the presence or in the absence of SycH.
The effectors yopOhis, yopHhis, yopThis and yopEhis were expressed in E.coli, respectively from
pML7, pML32, pML34 and pML33 . The chaperones sycO, sycH, sycT and sycE were
expressed from pML7, pSAM14, pSAM15 and pSAM13 respectively. The solubility of the
proteins was determined by ultracentrifugation as described in Letzelter et al. 2006. Insoluble
proteins are present in the pellet fraction (P), soluble proteins appear in the soluble fraction
(Sn).
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General discussion and conclusions:
What is the function of Class I chaperones? In this study, we demonstrated that SycO is a Class
I chaperone, specific for YopO. We investigated the interaction between YopO and SycO and
we discovered a new function for T3S effector chaperones. Various roles have been previously
attributed to Class I chaperones, like targeting, stabilization and unfolding of effectors. We will
address separately these different functions and see, in each case, if such a role can be
attributed to SycO.
Targeting: Do Class I chaperones constitute a secretion/translocation signal?
Chaperone knockouts usually present a deficiency to secrete their related effector. Based on
such observations, one of the first roles proposed for T3S chaperones was a targeting function
(Wattiau et al., 1994). Investigating the N-terminal secretion signal of secreted effectors, Cheng
et al. showed that the N-terminal secretion signal of YopE alone (YopE15), fused to the Npt
reporter protein allows the secretion of the hybrid protein. Expectedly, a frameshifted signal
fused to the same reporter cannot be secreted (Cheng et al., 1997). However, a YopE-Npt
fusion, with a frameshifted secretion signal is secreted by the wild-type, but not by a sycE
mutant bacteria. Thus, Cheng et al. proposed that the binding of SycE to the CBD of the YopE-
Npt fusion constitutes an alternative secretion signal. Similar observations have been made by
Lloyd et al. (Lloyd et al., 2001). These authors used YopE with different frameshifts (+/-1, +/-2)
in the first 13 residues of the N-terminal signal. The signal frameshifted YopE proteins were all
secreted by the wild-type bacteria in vitro. But, they all failed to be secreted by yerA (sycE)
mutant bacteria. Further, the authors replaced the N-terminal signal of YopE with artificial polar,
hydrophobic or amphipathic sequences. It turned out that only a N-terminal synthetic
amphipathic sequence consisting of alternating serine and isoleucine residues was secreted,
both in the presence and in the absence of YerA (SycE). Neither poly-serine nor poly-isoleucine
sequences permitted secretion of YopE, despite the presence of YerA (SycE). These results
suggest that the N-terminal sequence of YopE is critical for secretion, even in the presence of
the chaperone. Therefore, even if chaperones apparently assist the secretion of their substrate,
they cannot be considered as a secretion signal on their own.
Boyd et al. demonstrated that a Yersinia poly-effector mutant (ΔHOPEMT) can translocate
YopE15-Cya as efficiently as YopE130-Cya. A mutant deprived of YopH, YopE and YopT is also
able to deliver YopEΔ17–77. SycE cannot bind YopE15-Cya or YopEΔ17–77 (Boyd et al., 2000). Thus,
the N-terminal signal sequence of YopE is sufficient for delivery into eukaryotic cells and SycE
is dispensable for the export. The authors proposed that chaperones would actually assist the
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export by helping their substrate to compete for delivery to the T3S apparatus. Indeed,
However, the fact that the SycE-binding site and SycE are necessary for delivery of YopE by
wild-type Yersinia suggested to the authors that chaperones could help effectors to compete
against each other to be delivered. We made similar observations with SycO and we excluded
that SycO could constitute an export signal for YopO. Indeed, YopO could be secreted by the
sycO mutant bacteria in vitro. Moreover, YopOΔ20-77 -which cannot bind SycO- could be secreted
in vitro by the wild-type bacteria as well as by the sycO mutant bacteria. During cell infection,
YopO143 Δ20-77 (ΔCBD) fused to the Cya reporter could be translocated into host cells, but only by
multi-effectors mutants (ΔHOPEMT). The fact that YopO deprived of its CBD is less efficiently
translocated does not prove that the CBD and the chaperone are targeting factors. Indeed, the
system adapted to the constraint that it is the YopO-SycO complex and not YopO that needs to
be directed to the injectisome. In addition, the presence of the chaperone has imposed the
constraint of "de-chaperonization", which was shown to be the task of the ATPase (Akeda and
Galan, 2005). The consequence of this is that the targeting of YopO evolved to allow its
translocation in the presence, and after displacement, of SycO. By deleting the CBD, we just
have created a new secretion substrate that can be targeted, but whose signal is not optimized.
As the export process can work without chaperones, we exclude that they constitute a export
signal. However in the wild-type context it appears that the chaperones are necessary to the
export of their substrate. How are Class I chaperones involved in the export of their substrate?
We showed that YopO could be secreted in vitro by the sycO mutant. However, during cell
infection, no YopO is translocated into the host cells by the chaperone knockout. We did not
investigate the reasons for the differences observed between Ca2+-chelation mediated secretion
and contact-mediated translocation, but these two events must involve mechanistically distinct
processes. In vitro secretion is a 3 to 4 hours incubation of the bacteria in conditions where T3S
is deregulated and secretes continuously, whereas translocation into eukaryotic cells is a fast
process. In Shigella, half of the pool of pre-synthesized effectors is released within the 250
seconds following contact (Enninga et al., 2005). Previous studies in Shigella showed that
secretion of IpaA in the absence of the chaperone Spa15 could occur in vitro in a co-
translationnal way. However, the first burst of secretion observed (first 30 minutes) was strictly
post-translationnal and chaperone dependent (Page et al., 2002). Our results also suggest that
secretion in Ca2+-deprivation conditions might occur both, by post-translational and co-
translational mechanisms, while contact-mediated translocation is probably exclusively post-
translational. Thus, our data fit very well with the idea that the chaperone would be required for
export of pre-synthesized YopO and not for export of YopO synthesized while secretion is
active. This constraint implies that chaperones are involved in the storage of effectors. This
suggestion is in accordance with our solubility studies. In the absence of their chaperones
YopO, YopE and YopT aggregate in the bacteria. This state is not suitable for the uptake of the
proteins by the T3S. Thus, chaperones keep their substrate soluble and fit for export.
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Structural data were also analyzed to determine what could be the role of chaperones in
targeting. Comparing the structure the YopE-SycE complex with the SptP-SicP complex of
Salmonella, Birtalan et al. observed strong structural similarities. These authors proposed that
effectors in complex with the chaperones would constitute a three-dimensional signal (Birtalan
et al., 2002). However, recent studies including additional new complexes like YopN-SycN-YscB
(Schubot et al., 2005) or SicA-InvB (Lilic et al., 2006) revealed sufficient structural diversity
between the complexes to discard the idea of a conserved three dimensional signal (Lilic et al.,
2006). Nevertheless, Lilic et al. adapted another hypothesis proposed previously by Birtalan et
al. where chaperones “prime the secretion”. Chaperones would keep the CBD segment of
polypeptide unfolded in a “secretion competent state”. By this mechanism the chaperone could
help the recognition process by presenting the N-terminal secretion signal to the apparatus, by
promoting the interaction with the ATPase and facilitating the unfolding of the effector as
demonstrated by Akeda and Galan (Akeda and Galan, 2005).
Stabilization:  Are Class I chaperones stabilizing their substrate?
Several Class I chaperones are stabilizing their associated effector. It has been demonstrated
for the chaperone-effector complex SycE-YopE (Frithz-Lindsten et al., 1995), SicP-SptP (Fu
and Galan, 1998) and IpgE-IpgD (Niebuhr et al., 2000). The stability kinetics of YopO in the
wild-type and the sycO mutant were similar. SycO could apparently stabilize YopO inside the
bacteria (cf. unpublished results). However as we mentioned before, these preliminary
experiments should be confirmed.
YopO (Letzelter et al., 2006), YopE (Frithz-Lindsten et al., 1995), SptP (Fu and Galan, 1998),
Tir (Abe et al., 1999), IpgD (Niebuhr et al., 2000), are all present at a lower level in the absence
of their chaperone. This might be the result of a lower stability and a decrease in the amount of
protein. Our data bring some arguments to explain this instability. Indeed, we observed that the
CBD of the effectors is aggregation prone and has to be covered by the chaperone. In the
absence of the chaperone, YopO, YopE or YopT aggregate. This protein state is not suitable for
the bacteria and aggregates are subjected to proteolysis. In contrast to the aforementioned
effectors, some others like YopH (Wattiau et al., 1994) or IpaA (Page et al., 2002) are stable in
the absence of their chaperone. Accordingly, YopH is as soluble with or without its chaperone
(Fig. 27).
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Folding:  Do Class I chaperones keep their effectors unfolded?
The idea that T3S chaperone keep their substrate completely unfolded can be definitely
discarded. CBDs wrap around chaperones dimers in an extended conformation, with no or little
secondary structure. However, it is now established that the uncovered part of the effectors is
folded. This appears directly on the crystal structures of chaperone effector complexes like
InvB-SipA (Lilic et al., 2006), SycN-YscB-YopN (Schubot et al., 2005). In addition, effectors like
YopE (Birtalan et al., 2002), YopH (Neumayer et al., 2004) and YopO (Letzelter et al., 2006)
were shown to keep their enzymatic activity in complex with their chaperone. These
observations not only discard the possibility that chaperones keep their substrate completely
unfolded, but also pinpoint another interesting fact. The CBD is not required for the catalytic
activity of the protein. We confirmed this observation by removing the CBD from YopO.
Therefore, if the chaperone and the CBD do not constitute a secretion signal and are not
needed for the catalytic activity of the protein, why would the system conserve such aggregation
prone CBDs?
Localization: Are CBDs membrane / sub-cellular localization domain?
The CBD apparently creates the need for the chaperone. But, as mentioned by Birtalan et al., it
is unlikely that chaperones exist simply to mask an aggregation-prone effector domain whose
only function is chaperone binding (Birtalan et al., 2002). Strikingly, in Yersinia all the effectors
having a chaperone have an activity on the actin cytoskeleton dynamics and are targeted to the
host cell membrane. Accordingly to our data, the CBD would play a role within the target cell,
once the effector is delivered. Indeed, the CBD of YopO overlaps a membrane localization
domain. Fused to EGFP this small region of YopO is sufficient to bring EGFP to the plasma
membrane of the eukaryotic cell. Thus, the CBD of YopO is an aggregation prone membrane
localization domain. By covering this domain, SycO prevents the aggregation of YopO and
allows its export.
What about other Yersinia effectors? The CBD of YopE and more precisely the residues 50-77
were shown to be “toxic” for Yersinia and to prevent secretion of YopE in the absence of the
chaperone SycE (Boyd et al., 2000). Purified YopE was shown to aggregate (Birtalan et al.,
2002). The addition of SycE, covering these residues (15 to 75), promotes the solubilization of
the effector (Birtalan et al., 2002); (Letzelter et al., 2006). In the eukaryotic cell, residues 54-75
of YopE were shown to be a membrane localization domain (Krall et al., 2004). Thus, the
situation is identical to YopO: SycE covers a membrane localization domain on YopE and keeps
it in a soluble state, suitable for export. Without SycT, YopT is also insoluble in E.coli (Letzelter
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et al., 2006). Translocated YopT has also been shown to localize to HeLa cell membranes
(Aepfelbacher et al., 2003). Concerning YopH, the situation is a bit more complex, as its CBD
partially overlaps the phosphotyrosine recognition domain (Montagna et al., 2001). YopH has
been shown to interact with focal adhesions (Persson et al., 1999) and other membrane
complexes (Black et al., 2000). Different domains of YopH, including its CBD, are involved in
interactions with the Fyn binding protein in macrophages (Yuan et al., 2005). Even though, the
CBD of YopH is not a membrane-targeting domain, it is also involved in sub-cellular localization.
However, YopN may not follow our hypothesis. YopN is quite unique in the Yop family. Although
it has two chaperones of the Class I, SycN (Iriarte and Cornelis, 1999b) and YscB (Day and
Plano, 1998), it is the only heterodimeric chaperone complex described. Contrary to what was
reported before (Boland et al., 1996), YopN has been showed to be translocated into host cells
(Cheng et al., 2001; Day et al., 2003). We observed that ectopically produced YopN-EGFP does
not go to the eukaryotic cell membrane. No other study addressed the question of intracellular
localization of YopN. Beside, YopN acts as a regulator of T3S (Ferracci et al., 2005; Forsberg et
al., 1991) and it has never been suggested to be an effector, what could explain why YopN
would not need a sub-cellular localization domain. This translocation could just be the way the
system eliminates a regulator when it is not needed anymore. However, YopN could also be a
bi-functional protein with one function in the bacterial cell (control) and one function in the host
cell (effector). Thus, one should test whether YopN is addressed to the membrane using other
approaches.
YopM and YopP/YopJ, in contrast are not targeted to membranes. YopM is migrating to the
nucleus (Benabdillah et al., 2004), and YopP/YopJ interacts with the MAP kinase pathway in the
cytosol (Orth, 2002). In agreement with our hypothesis, no specific chaperone was found for
them so far. There is almost no possibility to discover an additional chaperone for those two
effectors. One of the last orf from the Yersinia virulence plasmid (pYV) called orf155 turned out
to be sycO encoding the chaperone for YopO. Among the few orfs left, none presents the
potential to be a Class I chaperone. Either their sequence is too short and does not present the
characteristics of Class I chaperones, or they are not conserved in the three pathogenic spieces
(Y.enterocolitica, Y.pseudotuberculosis, Y.pestis).
Our hypothesis about chaperones covering a targeting domain could apply to chaperones of
effectors of other T3S systems. The best characterized effectors with a dedicated chaperone,
have an activity related to membranes. In Salmonella, SptP, SigD/SopB and SopE, SopE2,
SipA all have a Class I chaperone (SicP, SigE and InvB, respectively) and have been shown to
be membrane associated (Cain et al., 2004); (Norris et al., 1998). In Shigella, IpaA one of
Spa15 substrates contributes to the entry of the bacteria into cells by binding the focal adhesion
protein vinculin (Tran Van Nhieu et al., 2000). Finally, in enteropathogenic E. coli (EPEC), Tir is
the membrane associated intimin receptor and the effector Map (Mitochondria associated
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protein) was shown to act at the mitochondrial membrane level (Kenny and Jepson, 2000). Both
effectors have CesT for chaperone (Creasey et al., 2003).
Generally, there is a correlation between the presence of a chaperone and an activity of the
effector at the membrane of the target cell. Every domain might not be aggregation prone, but
could also generate a problem for T3S targeting, creating the need for the chaperone. Also, the
nature of the interaction between the “membrane localization domain” and the membrane itself
is not known. Since chaperone binding domains present hydrophobic patches to interact with
the chaperones and have a tendency to aggregate, they could have a direct affinity for the lipids
of the membrane. However, they could also be protein-protein interaction domains, binding
membrane-associated components. To take a broader view, we could propose that Class I
chaperones need to cover domains that are involved in sub-cellular localization of the effector in
the target cell.
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Outlooks :
We demonstrated that the CBD of YopO, YopE and probably YopT is an aggregation prone
membrane localization domain. In consistency with the literature, we propose that covering such
domain inside the bacterium would be a common role for type three effector chaperones.
In general, this hypothesis should be challenged with other effectors and T3S systems to see if
other CBDs are membrane or sub-cellular localization domains. Several questions were raised
by our study.
How are the CBDs targeted to eukaryotic membranes ?
- What is the nature of the interaction between the CBD and the eukaryotic membranes:
Protein-protein interactions, direct interaction with the lipids, post-translational
modifications?
- Which motifs or residues are involved in the targeting to the membrane?
- Are those residues the same as those involved in the intra-bacterial aggregation?
To understand the whole process of T3S, we could also further investigate the function of the
chaperone and the CBD inside the bacterium:
- Are CBDs folded in the absence of the chaperone as it is the case for the CBD of
YopH? (Evdokimov et al., 2001)
- Does this folding lead to the masking of the secretion signal as it could be the case for
YopH?
- Which elements of the chaperones or the chaperones-effector complexes are involved
in the interaction with the ATPase?
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Plasmids:
pYV derivatives    
Plasmids Characteristics References
pYVe227 Wild type pYV plasmid from
Y.enterocolitica W227
(Cornelis et al., 1986)
pYV40 Wild type pYV plasmid from
Y.enterocolitica E40
(Sory and Cornelis, 1994)
pML4001 pYV40: sycO This study
pAB406 pYV40: yopOΔ65-558 (Mills et al., 1997)
pSW2276 pYV40: yscNΔ169-177 (Woestyn et al., 1994)
pIML421(ΔHOPEMT) pYV40: yopHΔ1-352, yopOΔ65-558, yopP23,
yopE21, yopM23, yopT135
(Iriarte and Cornelis, 1998)
pCNK4008
(ΔHOPEMNB)
pYV40: yopHΔ1-352, yopOΔ65-558, yopP23,
yopE21, yopM23, yopN45, yopBΔ89-217
(Neyt and Cornelis, 1999a) 
Clones
Plasmids Characteristics
Derivation and
oligonucleotides used
References
pAB6 pTM100::yopM100-cyaA' Boland et al. 1996
pAB29 pTM100::yopT124-cyaA' Iriarte et al. 1998
pCD10 pTM100
::yopO143 -cyaA'
(sycE promoter)
Unpublished
pCD11 pTM100
::yopO77 -cyaA'
(sycE promoter)
Deletion of the MunI/HindIII
fragment in pCD10
Unpublished
pISO56 pBBR1 MCS2::yopOflag
(yopE promoter)
Flag-tag insertion in pMAF60
*3688/3710
This study
pMAF60 pBBR1 MCS2::yopO
(yopE promoter)
Cloning of yopO from
pYOB2
3118/3119
This study
pML1 pEGFP(N)::yopO Cloning of yopO
3394/3395
This study
pML2 pEGFP(N)::yopOΔ20-77 Deletion from pML1
*(3396/3397)
This study
pML3 pEGFP(N)::yopOD267A Mutation on pML1
*(3484/3485)
This study
pML4 pBBR1 MCS2::sycO Cloning of sycO
3266/3271
This study
pML7 pET22::yopOhis Cloning of yopO
3523/3525
This study
pML8 pET22::yopOΔ20-77 his Deletion from pML7
*(3396/3397)
This study
pML9 pET22::sycO-yopOhis Cloning of sycO-yopO
 3524/3525
This study
pML10 pGEX-6p-1::yopO Cloning of yopO
3698/3699
This study
pML11 pGEX-6p-1::yopOΔ20-77 Deletion from pML10
*(3396/3397)
This study
pML12 pGEX-6p-1::yopOD267A Mutation on pML10
*(3484/3485)
This study
pML13 pGEX-6p-1::yopO200 Cloning of yopO200
3523/3908
This study
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pML14 pBAD::sycO Cloning of sycO
3268/3250
This study
pML15 pCDF::sycO Cloning of sycO
3268/3271
This study
pML16 pBBR1 MCS2::yopOΔ20-
77 flag (yopE promoter)
Deletion from pISO56
*(3396/3397)
This study
pML17 pGEX-6p-1::yopO20-77                  Cloning of yopO20-77
 4015/4028
This study
pML18 pKS::-250/sycO/+250 Cloning of -250/sycO/+250
3266/3267
This study
pML19 pKS::-250/ΔsycO/+250 Deletion of sycO from
pML18 *(3272/3273)
This study
pML26 pEGFP(N)::yopO20-80 Cloning of yopO20-80
4134/4079
This study
pML27 pEGFP(N)::yopO20-90 Cloning of yopO20-90
4134/4080
This study
pML31 pBBR1 MCS2::
yopO143 Δ20-77 -cyaA'
 (sycE promoter)
Deletion from pCD10
*(3396/3397)
This study
pML32 pET22::yopHhis Cloning of yopH
4305/4308
This study
pML33 pET22::yopEhis Cloning of yopE
4306/4309
This study
pML34 pET22::yopThis Cloning of yopT
4307/4310
This study
pML36 pEGFP(N)::yopP Cloning of yopP This study
pML37 pEGFP(N)::yopN Cloning of yopN This study
pMSK3 pTM100::yopP99-cyaA' Unpublished
pMSLH99 pTM100::yopH99-cyaA' Sory et al. 1995
pMSL28 yopE130--cyaA' Unpublished
pMSLE20 pTM100::yopE20 -cyaA' (Sory et al., 1995)
pSAM10 pEGFP(N)::yopE1-90 Cloning of yopE1-90
4293/4294
This study
pSAM11 pEGFP(N)::yopH1-90 Cloning of yopH1-90
4295/4296
This study
pSAM12 pEGFP(N)::yopT1-124 Cloning of yopT1-124
4297/4298
This study
pSAM13 pCDF::sycE Cloning of sycE
4301/4302
This study
pSAM14 pCDF::sycH Cloning of sycH
4303/4304
This study
pSAM15 pCDF::sycT Cloning of sycT
4299/4300
This study
pYOB2 pCNR26::yopO
(yopE promoter)
Cloning of yopO
471/473
This study
Cloning vectors
Plasmids Characteristics References
pBADmyc-his A pBAD promoter, high copy Invitrogen
pBBR1-MCS2 medium-low copy (Kovach et al., 1995)
pBluescript II KS (+)  Stratagene
pCDF-Duet T7 promoter  Novagen
pCNR26 yopE promoter (Sarker et al., 1998)
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pEGFP-N1 CMV IE promoter
BD Biosciences
Clontech
pET22 T7 promoter, lac operator, high copy  Novagen
pGEX-6p-1 pTac promoter Amersham
pTM100 pACYC184-oriT
(Michiels and Cornelis,
1991)
Suicide Vectors, mutator 
Plasmids Characteristics References
pKNG101 ori R6K, mob RK2, strAB, sacBR  (Kaniga et al., 1991)
pML20 pKNG101::-250/ΔsycO/+250 This study 
Oligonucleotides labeled with * were used to delete or mutate domains by inverse polymerase
chain reaction, using Pfu turbo polymerase (Stratagene).
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